WO2007000966A1 - Container for sampleing specimen - Google Patents

Container for sampleing specimen Download PDF

Info

Publication number
WO2007000966A1
WO2007000966A1 PCT/JP2006/312706 JP2006312706W WO2007000966A1 WO 2007000966 A1 WO2007000966 A1 WO 2007000966A1 JP 2006312706 W JP2006312706 W JP 2006312706W WO 2007000966 A1 WO2007000966 A1 WO 2007000966A1
Authority
WO
WIPO (PCT)
Prior art keywords
blood
serum
opening
plasma
collection container
Prior art date
Application number
PCT/JP2006/312706
Other languages
French (fr)
Japanese (ja)
Inventor
Ryusuke Okamoto
Katsuya Togawa
Masahiro Nakaizumi
Yutaka Sakakibara
Original Assignee
Sekisui Chemical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2005187124A external-priority patent/JP3890068B2/en
Priority claimed from JP2005187123A external-priority patent/JP3890067B2/en
Application filed by Sekisui Chemical Co., Ltd. filed Critical Sekisui Chemical Co., Ltd.
Publication of WO2007000966A1 publication Critical patent/WO2007000966A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • G01N33/491Blood by separating the blood components
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5021Test tubes specially adapted for centrifugation purposes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/02Adapting objects or devices to another
    • B01L2200/026Fluid interfacing between devices or objects, e.g. connectors, inlet details
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/06Auxiliary integrated devices, integrated components
    • B01L2300/0681Filter

Definitions

  • the present invention relates to a specimen collection container used for separating plasma or serum from blood and examining components in the plasma or serum, and more specifically, the separated plasma or serum is red blood cells.
  • Background art on a sample collection container that can reliably prevent contamination by components that have leaked power and can easily extract separated plasma or serum
  • centrifugation has been used to remove blood cell components from blood and obtain plasma or serum necessary for clinical examination.
  • the work such as the coagulation process and the process of transferring the supernatant plasma or serum after separation is complicated.
  • Patent Document 1 discloses an example of a blood test container that makes it possible to separate plasma or serum from collected blood and to take out the separated plasma or serum. With reference to FIG. 19, the blood test container shown in Patent Document 1 will be described.
  • a blood test container 101 is an airtight container having an outer tube 102, a cylindrical member 103, and a stopper 104, and the inside is decompressed. .
  • a cylindrical member 103 is inserted into the outer tube 102.
  • the outer tube 102 is a bottomed tubular container, and the outer tube 102 has an opening 102a at the upper end.
  • the cylindrical member 103 has an opening 103a at its upper end.
  • a filter 105 is housed in the lower part of the cylindrical member 103.
  • the filter 105 includes a filter member 106 and a blood cell stop film 107 disposed below the filter member 106.
  • the filter member 106 is made of a filter material that moves plasma or serum faster than blood cell components.
  • blood The sphere stop membrane 107 is provided for capturing blood cells and preventing the blood cells from being mixed into the separated plasma or serum.
  • a protruding portion 103b protruding downward is formed at the lower end of the cylindrical member 103.
  • a plasma or serum channel 108 is provided in the protruding portion 103b.
  • the plasma or serum channel 108 is opposed to the lower surface of the blood cell stop film 107 and is provided so as to extend downward in the protrusion 103b.
  • the plasma or serum separated by the filter member 106 flows down from the plasma or serum channel 108 to the lower plasma or serum container 109.
  • the space above the filter member 105 constitutes a blood storage unit 110.
  • the plug 104 has a gripping portion 104a, a large diameter portion 104b, and a small diameter portion 104c.
  • the large diameter portion 104b has a larger diameter than the small diameter portion 104c.
  • the small diameter portion 104c is press-fitted into the opening 103a of the cylindrical member 103, and the large diameter portion 104b is press-fitted into the opening 102a of the outer tube 102.
  • blood is collected in the blood storage section 110 by a pressure difference between the inside and outside by inserting a blood collection needle through the plug 104.
  • the collected blood is filtered by the filter 105.
  • plasma or serum moves downward more rapidly than the blood cell component.
  • plasma or serum passes through the blood cell stop membrane 107 and reaches the plasma or serum channel 108.
  • the plasma or serum flows down to the plasma or serum storage unit 109.
  • blood cells are captured by the blood cell stop film 107. Filtration stops when the blood cell stop membrane 107 is blocked by blood cells.
  • the plug member 104 pressed into the opening 102a of the outer tube 102 is removed together with the tubular member 103. In this way, the separated plasma or serum can be removed.
  • Patent Document 1 Japanese Unexamined Patent Application Publication No. 2004-325412
  • blood cells are captured by blood cell stop film 107, blood cell stop film 107 is blocked, and filtration stops.
  • the filter is left for a long time after the filtration is completed, the red blood cells captured by the blood cell arresting membrane 107 may be destroyed and the components in the red blood cells may leak.
  • the leaked erythrocyte component is partly stored in the plasma or serum flow path 108. Or there was a possibility that components in erythrocytes might be mixed in serum.
  • blood at the tip of the blood collection needle may flow at high speed.
  • the components in red blood cells are mixed into plasma or serum stored in plasma or serum storage unit 109. In this case, when the obtained plasma or serum was examined, the contaminated erythrocyte component greatly affected the test result, and it was impossible to obtain a highly reliable test result.
  • an object of the present invention is to separate blood into blood cell components and plasma or serum in a short time, and whether the separated plasma or serum is red blood cells.
  • a sample collection container is a sample collection container used for separating plasma or serum from blood and examining components of the plasma or serum.
  • a cylindrical container body having an opening of 1 and a second opening on the other end side, a first stopper fitted in the first opening, and a second opening.
  • a cylindrical container body having a first internal space in which blood is collected on the first opening side and blood-pressure separated plasma on the second opening side Or a second internal space in which serum is accommodated, and is disposed between the first and second internal spaces, and blood collected in the first internal space is converted into a blood cell component and plasma or serum.
  • a blood separation filter for separating the blood.
  • the first stopper and the first stopper so that blood supplied from the first opening side is contacted before the blood separation filter.
  • a blood diffusing material that is disposed between the blood separation filter and allows blood to flow through the blood separation filter while allowing the blood to pass through while being diffused in various directions.
  • the specimen collection container is disposed between a blood separation filter and the second internal space, and allows passage of blood cell components separated by the blood separation filter.
  • a blood cell stop filter for preventing the blood cell is further provided.
  • the blood cell can be reliably prevented from passing by the blood cell stop filter when blood is separated, and contamination of red blood cells or white blood cells into plasma or serum can be prevented more reliably.
  • the specimen collection container is disposed between the blood separation filter and the second internal space, and is brought into contact with plasma or serum separated by the blood separation filter. And a flow path closing member that swells and closes the flow path.
  • the flow path is closed by swelling of the flow path closing member due to contact with plasma or serum. Therefore, when the blood cell component reaches the flow path blocking member later than the plasma or serum due to the difference in the moving speed, the flow path is closed, so that the plasma or serum stored in the second internal space is blocked. It is possible to prevent blood cells from being mixed in.
  • the sample collection container is such that the first opening is on the lower side and the second opening is on the upper side.
  • the second opening force and the second plug may be removed. Since the flow path is closed by the flow path closing member, the plasma or serum contained in the second internal space does not reach the blood separation filter or the first internal space. Therefore, since plasma or serum is difficult to come into contact with blood cells or erythrocyte components, contamination of plasma or serum can be prevented. Therefore, uncontaminated plasma or serum can be easily and reliably removed from the second opening. In addition, it is possible to more reliably prevent laboratory technicians from being infected with pathogens in the blood by contact with the separated plasma or serum.
  • the flow path blocking member is disposed between the blood cell stop filter and the second internal space.
  • the first opening is removed when taking out the plasma or serum contained in the second internal space.
  • plasma or serum does not reach the hemocytosis filter. Therefore, it is possible to more reliably prevent the red blood cells and white blood cells trapped by the blood cell stop filter from being mixed into the plasma or serum.
  • the outer surface of the second stopper is covered with a cover that prevents the second stopper from being pierced by a blood collection needle or syringe. Covered. In this case, it is possible to prevent blood from being collected in the second internal space by accidentally inserting a blood collection needle or syringe into the second stopper.
  • the inner peripheral surface of the cylindrical container body is tapered toward the first opening side.
  • the second internal space Even when the amount of plasma or serum contained in the container is small, the liquid level becomes high and the liquid level becomes close to the second opening, so that it is possible to more easily remove plasma or serum. .
  • the first and second stoppers are airtightly attached to the first and second openings of the container body, and the inside of the container body is decompressed. ing. In this case, since the inside is depressurized, plasma or serum can be rapidly separated from blood by the pressure difference.
  • the cylindrical container body has a first opening on one end side and a second opening on the other end side.
  • the blood collected in the first internal space is separated into a blood cell component and plasma or serum between the first internal space on the first opening side and the second internal space on the second opening side. Therefore, when separating blood, the blood separation filter uses the difference in moving speed between blood cell components and plasma or serum, and blood is separated from blood cell components and plasma or serum. And can be separated.
  • the second plug fitted in the second opening For example, a blood collection needle or a syringe is pierced, or the second plug fitted in the second opening is removed, and the plasma or serum contained in the second internal space can be easily removed. It can be taken out.
  • blood diffusion material When the blood diffusion material is further provided, blood is diffused in multiple directions in the blood diffusion material, and the blood reaches the blood separation material. That is, in the sample collection container of the present invention, when blood is collected, the blood cells are prevented from directly colliding with the blood separation material, and the blood is diffused in multiple directions and flows into the blood separation material. Therefore, plasma or serum can be obtained without being contaminated with red blood cell components that are difficult to destroy.
  • FIG. 1 is a front view showing a sample collection container according to an embodiment of the present invention.
  • FIG. 2 is a front sectional view showing a sample collection container according to one embodiment of the present invention.
  • FIG. 3 is a front cross-sectional view showing a state immediately after blood is collected in a sample collection container according to an embodiment of the present invention.
  • FIG. 4 is a front cross-sectional view showing a state in the middle of the stage where blood collected in the sample collection container according to one embodiment of the present invention is separated.
  • FIG. 5 is a front sectional view showing a state in which separated blood color or serum is taken out from a sample collection container according to one embodiment of the present invention.
  • FIG. 6 is a front view showing a sample collection container according to another embodiment of the present invention.
  • FIG. 7 is a front sectional view showing a sample collection container according to another embodiment of the present invention.
  • FIG. 8 is a front view showing a sample collection container according to another embodiment of the present invention.
  • FIG. 9 is a front cross-sectional view showing a sample collection container according to another embodiment of the present invention.
  • FIG. 10 is a front sectional view showing a sample collection container according to still another embodiment of the present invention.
  • FIG. 11 is a front sectional view showing a sample collection container according to still another embodiment of the present invention.
  • FIG. 12 (a) and (b) are a front view and a front sectional view showing a sample collection container according to still another embodiment of the present invention.
  • FIG. 13 is a view for explaining a method of using a sample collection container according to still another embodiment of the present invention, and shows a state before a syringe from which blood has been collected is pierced into the sample collection container FIG.
  • FIG. 14 is a diagram for explaining a method of using a sample collection container according to still another embodiment of the present invention.
  • the syringe force from which blood is collected is allowed to flow into the sample collection container.
  • It is front sectional drawing which shows the state in the middle stage.
  • FIG. 15 is a view for explaining a method of using a sample collection container according to still another embodiment of the present invention, and shows a state after separated plasma or serum is accommodated in the internal space. It is front sectional drawing.
  • FIG. 16 illustrates a method of using a specimen collection container according to still another embodiment of the present invention.
  • FIG. 5 is a front sectional view showing a state when the separated plasma or serum is taken out.
  • FIG. 17 is a front view and a front sectional view showing a specimen collection container according to another embodiment of the present invention.
  • FIG. 18 (a) and (b) are a front view and a front sectional view showing a sample collection container according to another embodiment of the present invention.
  • FIG. 19 is a front sectional view showing an example of a conventional specimen collection container.
  • the cylindrical container body used for the sample collection container according to the present invention has a first opening on one end side and a second opening on the other end side which is the opposite end, and the first opening A first internal space is provided on the side, and a second internal space is provided on the second opening side.
  • the shape of the cylindrical container body is not particularly limited, and examples thereof include a rectangular tube shape and a cylindrical shape.
  • the material of the cylindrical container body is not particularly limited as long as it has air impermeability.
  • Examples of the material for the container body include synthetic resins such as polyethylene terephthalate.
  • the air non-permeation performance may be improved by vapor deposition of metal or silicon on the surface.
  • the size and shape of the container body are not particularly limited. However, considering the rack compatibility of general clinical laboratory equipment, for example, the outer diameter is 16mm x the length is up to 100mm. Shape. [0033] (first plug)
  • the first plug is not particularly limited as long as it is made of a material that is impermeable to air and can be pierced by a blood collection needle or syringe.
  • the material constituting the first plug body include elastic bodies such as natural rubber, butyl rubber, isoprene rubber, or thermoplastic elastomer.
  • the second plug is not particularly limited as long as it is made of an air impermeable material.
  • the material constituting the second plug body include elastic bodies such as natural rubber, butyl rubber, isoprene rubber, and thermoplastic elastomer.
  • the outer surface of the second plug is covered with a cover made of metal, synthetic resin or the like. If the cover is provided without being pierced by the blood collection needle or syringe, the blood collection needle or syringe is accidentally pierced by the second stopper, and blood is collected in the second internal space. Can be prevented.
  • the material constituting the cover is not particularly limited, and examples thereof include polypropylene, polyethylene, polyethylene terephthalate, and polycarbonate.
  • Examples of the blood separation filter used in the present invention include an assembly of ultrafine fibers, a foam or sintered body having continuous bubbles, a hollow fiber membrane, a porous membrane, porous particles, a plurality of grooves and Z or pores.
  • the force that the film can have is not limited to the above examples as long as blood can be substantially separated into blood cells and plasma or serum when the blood flow passes.
  • the blood cell component may be separated by being captured inside the filter, or may be separated by the difference in the moving speed between the blood cell component and the plasma or serum component.
  • the blood separation filter can be divided into an asymmetric filter and a symmetric filter.
  • the asymmetric filter is a general term for a filter having a structure in which the diameter of a hole through which blood flows from the inflow side to the outflow side becomes small.
  • Other blood separation filters are collectively referred to as symmetric filters.
  • the symmetrical filter having a number of holes through which blood flows preferably has an average pore diameter of 1 ⁇ m or more and 10 ⁇ m or less. More preferably, it is in the range of 2 / zm or more and 8 / zm or less. If the average pore size is less than 1 m, hemolysis may occur, and if it exceeds 10 m, separation of blood cells from plasma or serum may be significantly worsened.
  • an average pore diameter of the holes through which blood flows is preferably 0.01 ⁇ m or more and 10 ⁇ m or less. More preferably, it is 0.1 ⁇ m or more and 6 ⁇ m or less. Average pore size ⁇ ⁇ . From 01 ⁇ m / J ⁇ If the mean pore size is larger than 10 m, blood cell components may become clogged and may not be separated. Separation may be significantly worse.
  • the blood separation filter is composed of an aggregate of ultrafine fibers
  • fiber bodies having an average fiber diameter in the range of 0.5 to 3.0 ⁇ m are accumulated. If the average fiber diameter is smaller than 0, hemolysis is likely to occur when blood is separated. If the average fiber diameter is larger than 3.0 m, it is necessary to form a blood separation filter at a high density in order to separate blood cells from plasma or serum, and the amount of fibers used increases and the cost increases. .
  • the average fiber diameter is more preferably in the range of 0.5 to 2.
  • the average density of the blood separation filter when installed in the container body is preferably in the range of 0. 1 ⁇ 0. 5g / cm 3. If the average density is lower than 0.1 lg / cm 3 , blood separation may not be performed effectively, and the amount of plasma or serum obtained may be reduced. When the average density is higher than 0.5 g / cm 3 , the load on red blood cells is increased, and hemolysis is likely to occur. In order to separate blood more efficiently, the average density is preferably in the range of 0.15 to 0.40 gZcm 3 .
  • the blood separation filter may have a property of adsorbing components in blood.
  • the blood separation filter may be subjected to a surface treatment in order to suppress or control the adsorption of components in the blood.
  • the surface treatment agent is not particularly limited, but may be a polyether-based or silicone-based lubricant, such as polybulal alcohol or polybulurpyrrolidone. Examples thereof include hydrophilic polymers, natural hydrophilic polymers, and polymer surfactants.
  • the surface of the blood separation filter may be hydrophilized by chemical treatment with an oxidizing agent, plasma treatment, or the like. Conversely, water repellent treatment may be applied as in hydrophobic silicone and fluorine surface treatment agents.
  • a blood cell stop filter capable of preventing passage of red blood cells is disposed between the blood separation filter and the second internal space.
  • the material of the blood cell stopping filter is not particularly limited as long as it can prevent passage of red blood cells.
  • examples of the material include polyvinylidene difluoride, polytetrafluoroethylene, cellulose acetate, nitrocellulose, polycarbonate, polyethylene terephthalate, polyethylene, polypropylene, glass fiber, polysilicate, salt butyl, silver, and the like. be able to.
  • the blood cell stop filter preferably also has a porous material force having pores that prevent passage of red blood cells. If the hemostasis filter is constructed using a porous material, plasma or serum can pass through.
  • the porous substance constituting the blood cell stopping filter is not particularly limited as long as it has a pore diameter in a range that can prevent passage of red blood cells, and a porous membrane in which a number of through-holes extend from one side to many sides.
  • various porous materials can be used.
  • the pore size is preferably 1 m or less. If the pore size is too small, clogging may occur due to protein components in the blood. Therefore, the pore size is preferably 0.01 m or more. In order to effectively prevent the passage of erythrocytes, the pore diameter is more preferably in the range of 0.05 / zm to the following.
  • the surface of the blood cell stop filter may be hydrophilically treated!
  • the method of hydrophilic treatment is a force that includes plasma treatment, coating with a hydrophilic polymer, etc. The method is not limited to these methods, and other methods may be used.
  • a channel closing member that swells when contacted with plasma or serum is disposed in the channel.
  • the flow path blocking member includes a blood separation filter and a second inner member. U, which is preferably disposed between the blood stop filter and the second internal space, is preferably disposed between the subspace.
  • the material of the flow path blocking member used in the present invention is not particularly limited, but has a hydrophilic functional group in the molecular skeleton and has the property of absorbing the same amount or more of water with respect to its own weight. Fat is preferred.
  • Specific examples of the material of the flow path blocking member include poly (alkali acrylate) metal salt-based resins or copolymers thereof and their crosslinked products, polyacrylamide-based resins or their copolymers and their crosslinked products.
  • Poly-N-bulucetamide-based resins or copolymers thereof and cross-linked products thereof silicon-based resins or copolymers thereof and cross-linked products thereof, polyvinyl ether-based resins and copolymers thereof, and These cross-linked products include polyalkylene oxide-based resins or copolymers thereof and cross-linked products thereof, polyvinyl alcohol, polyvinyl pyrrolidone or copolymers thereof and cross-linked products thereof.
  • the flow path blocking member a powder or granular material may be used, or a film or sheet shaped material may be used. If the channel closing member is formed into a sheet shape, it can be easily installed in the channel. As the channel closing member, a paste, slurry, solution or the like may be used, which may be added and dried.
  • the flow path closing member swells itself by being in contact with plasma or serum, and closes the flow path. Therefore, the required amount of the flow path closing member varies depending on the flow path volume to be closed, the swelling rate and the swelling speed of the flow path closing member. Therefore, the optimum amount of the channel closing member is calculated from the channel volume to be closed, the swelling rate and the swelling speed of the channel closing member.
  • the channel volume to be occluded is set in a range in which moisture in the blood is absorbed and the collected amount of the sample does not decrease.
  • the amount of the channel closing member for blocking is increased, so that the amount of collected sample may be reduced.
  • the channel volume to be closed is in the range of 0.005 to 1. Ocm 3 .
  • the volume of the flow path closing member is preferably in the range of 5 to 95% with respect to the volume of the flow path to be closed. If the volume of the flow path blocking member is less than 5% of the volume of the flow path to be blocked, the time until the flow path is closed becomes longer, so components leaking from red blood cells are mixed into the separated plasma or serum. There is a fear. Flow blocked by the volume of the flow path blocking member If the volume is larger than 95%, the flow path may be blocked before all plasma or serum is collected, which may reduce the collection efficiency of plasma or serum.
  • the present invention it is preferable to secure a gas tightness in the container main body by the first and second air-impermeable plugs to obtain a vacuum specimen collection container.
  • the pressure in the specimen collection container is preferably in the range of 10 to 90 kPa in order to exert the driving force of blood filtration and prevent the destruction of red blood cells due to the load on the blood cell components. More preferably, it is the range of 30-80kPa. If the pressure is higher than 90 kPa, it may take a long time to separate the blood. If the pressure is lower than lOkPa, the red blood cells are destroyed and the components in the red blood cells are likely to leak.
  • a sample collection container according to an embodiment of the present invention is shown in a front view in FIG. 1 and a front sectional view in FIG.
  • the sample collection container 1 has a cylindrical container body 2 having a first opening 2a on one end side and a second opening 2b on the other end side. .
  • the end of the container body 2 on the first 0 opening 2 side has a tapered shape of an inverted frustoconical shape, and the opening diameter of the first opening 2a is made smaller than the opening diameter of the second opening 2b.
  • the sample collection container 1 is shown so that the first opening 2a is on the lower side and the second opening 2b is on the upper side.
  • the first plug 2 is fitted in the first opening 2a so as to hermetically seal the inside.
  • the first plug 3 has a large diameter portion 3a and a small diameter portion 3b.
  • the large diameter portion 3a has a larger diameter than the small diameter portion 3b.
  • an inverted frustoconical recess 3c is provided in the center of the outer surface of the first stopper, and the center of the first stopper is thin. It has become.
  • the small diameter portion 3b is press-fitted into the first opening 2a, whereby the first opening 2a is hermetically sealed by the first plug body 3.
  • the second plug 4 is detachably fitted in the second opening 2b.
  • the second plug 4 has a large diameter part 4a and a small diameter part 4b.
  • the large diameter part 4a has a larger diameter than the small diameter part 4b.
  • the large diameter portion 4a has a diameter larger than the outer diameter of the container body 2.
  • the small diameter portion 4b is press-fitted into the second opening 2b, and the second opening 2b is hermetically sealed by the second plug body 4.
  • the inside of the sample collection container 1 is depressurized.
  • the outer surface of the second plug 4 is covered with a cover 5 in order to prevent the second plug 4 from being accidentally pierced by a blood collection needle or syringe.
  • the entire outer surface of the large diameter portion 4a is covered with the cover 5.
  • the cover 5 extends further downward from the outer peripheral side surface of the large diameter portion 4a, and the lower end 5a of the cover 5 reaches the outer peripheral side surface of the second opening 2b.
  • an annular protrusion 5b is formed on the inner peripheral side surface of the cover 5.
  • the inner diameter of the cover 5 is equal to or slightly smaller than the outer diameter of the large diameter portion 4a.
  • the inner diameter of the annular protrusion 5b is equal to or slightly smaller than the outer diameter of the small diameter portion 4b.
  • the front end surface 5c of the annular protrusion 5b is in contact with the outer peripheral side surface of the small diameter portion 4b, and the side surface 5d of the annular protrusion 5b contacts the step portion 4c between the large diameter portion 4a and the small diameter portion 4b. It is in contact.
  • a plurality of steps 5e are formed on the outer peripheral side surface of the force bar 5 so that the cover 5 can be easily removed together with the second plug 4 so that it can be easily grasped.
  • a first internal space A1 in which blood is collected is disposed on the first opening 2a side, and blood is disposed on the second opening 2b side.
  • a second internal space A2 for accommodating plasma or serum separated from the blood is disposed.
  • the first internal space A1 is a part from which blood is collected
  • the second internal space A2 is a part from which separated plasma or serum is stored and taken out.
  • a blood separation filter 6 for separating blood collected in the first internal space A1 into a blood cell component and plasma or serum is arranged.
  • a disc-shaped flow path blocking member 7 made of a resin that swells when contacted with plasma or serum separated by the blood separation filter 6 is disposed. ing. In the initial state, that is, before swelling, a hole 7a is formed in the center of the channel closing member 7 so as to secure a channel through which plasma or serum flows.
  • annular protrusion 2c is provided on the inner peripheral surface of the container body 2 between the flow path closing member 7 and the second internal space A2.
  • the annular protrusion 2c forms an opening 2d surrounded by the annular protrusion 2c, and constitutes a hollow channel. Closed flow path as described above
  • the hole 7a of the blocking member 7 is connected to the opening 2d.
  • a taper 2e is attached to the annular protrusion 2c on the inner peripheral surface of the container body 2 toward the flow path closing member 7 side.
  • a disc-shaped blood cell stop filter 8 that prevents passage of blood cells separated by the blood separation filter 6 is disposed.
  • the blood cell stop filter 8 is in contact with the blood separation filter 6 and is spaced apart from the flow path blocking member 7 by a certain distance.
  • FIG. 3 shows a state immediately after blood is collected in the specimen collection container 1
  • FIG. 4 shows a state in the middle of separation of the blood collected in the specimen collection container 1
  • FIG. The state of taking out the plasma or serum from the sample collection container 1 is shown in a front sectional view.
  • FIGS. 3 and 4 show the sample collection container 1 in the state shown in FIGS. 1 and 2 upside down. As shown in FIGS. 3 and 4, when collecting and separating blood, the sample collection container 1 is arranged so that the first opening 2a is on the upper side and the second opening 2b is on the lower side.
  • a blood collection needle 11 is inserted into the first stopper 2a in order to introduce blood into the first internal space.
  • the sample collection container 1 is depressurized! Therefore, blood is guided from the blood collection needle 11 to the first internal space A1, and also reaches the blood separation filter 6. After blood is introduced, the blood collection needle is removed.
  • the sample collection container 1 When collecting blood, the sample collection container 1 may be attached to a blood collection holder and vacuum collected using a blood collection needle directly, or after collecting blood into a syringe, the syringe needle may be removed.
  • the first plug 3 may be inserted to guide blood. After the blood is collected, the blood collection needle or syringe needle is preferably removed as described above. The first stopper 3 may remain inserted.
  • the blood supplied to the first internal space A 1 passes through the blood separation filter 6.
  • plasma or serum moves faster than blood cell components.
  • the plasma or serum that has moved relatively fast reaches the blood cell stop filter 8 first and passes through the blood cell stop filter 8. Then, the plasma or serum passes through the hole 7a of the flow path closing member 7, flows down from the hollow flow path of the opening 2d of the container body 2, and flows into the second Housed in internal space A2.
  • Blood cells that have moved at a lower speed than plasma or serum do not pass through the blood cell stop filter 8 even if they reach the blood cell stop filter 8. Therefore, blood cells will not be mixed into the plasma or serum contained in the second internal space A2.
  • the flow path closing member 7 gradually swells when it comes into contact with plasma or serum, and closes the flow path after the plasma or serum to be stored has passed. More specifically, the blood flow blocking member 7 swells after passing through the flow channel portion where the plasma or serum force flow channel blocking member 7 that has moved relatively fast in the blood separation filter 6 is disposed. To do. That is, the hole 7a of the flow path closing member 7 is closed, and the flow path closing member 7 closes the flow path.
  • the sample collection container 1 is preferably turned upside down.
  • the sample collection container 1 since the flow path is closed by the flow path closing member 7, the sample collection container 1 can be turned upside down, and the plasma or serum strength blood separation filter 6 contained in the second internal space A2 It does not lead to. That is, the separated plasma or serum is prevented from coming into contact with blood cells or erythrocyte components and contaminating the plasma or serum.
  • the second plug 4 that is press-fitted into the second opening 2b is removed.
  • plasma or serum can be sucked into the container from the second opening 2b using a pipette or the like and used for clinical examination.
  • plasma or serum can be taken directly from the nozzle of the test equipment.
  • the taper 2e is attached to the inner peripheral surface of the container body 2, and the plasma or serum liquid level is brought closer to the second opening 2b. It is possible to take it out.
  • a sample collection container according to another embodiment of the present invention is shown in a front view in FIG. 6 and a front sectional view in FIG.
  • the sample collection container 21 shown in Figs. 6 and 7 is the same as that described above except that the shape of the first opening and the shape of the first stopper provided in the first opening are different. It is configured in the same way as the sample collection container 1.
  • the same reference numerals are given and description thereof is omitted.
  • the sample collection container 21 has a cylindrical container body 22 having a first opening 22a on one end side and a second opening 22b on the other end side.
  • the first opening 22a and the second opening 22b have the same opening diameter.
  • An annular protrusion 22c is provided on the inner peripheral surface of the container body 22 between the flow path closing member 7 and the second internal space A2.
  • the annular protrusion 22c forms an opening 22d surrounded by the annular protrusion 22c, and constitutes a hollow flow path.
  • a taper 22e is attached to the annular protrusion 22c on the inner peripheral surface of the container body 22 toward the flow path closing member 7 side.
  • a first plug 23 is fitted into the first opening 22a so as to hermetically seal the inside.
  • the first plug body 23 has a large diameter portion 23a and a small diameter portion 23b.
  • the large diameter portion 23a has a larger diameter than the small diameter portion 23b.
  • the large diameter portion 23a has a diameter larger than the outer diameter of the container body.
  • a hemispherical recess 23c is provided at the center of the outer surface of the first stopper 23.
  • the small diameter portion 23b is press-fitted into the first opening 22a, and the first opening 22a is hermetically sealed by the first plug body 23.
  • the second opening 22b is hermetically sealed using the second stopper 4 whose outer surface is covered with the cover 5, and the inside of the sample collection container 21 is decompressed.
  • the outer surface of the first plug 23 is covered with a cover 24.
  • the cover 24 is provided with a hole 24a in the concave portion 23c of the first plug 23 so that the first plug 23 is pierced by a blood collection needle or syringe. /!
  • the cover 24 extends further upward from the outer peripheral side surface of the large-diameter portion 23a, and the upper end 24b of the cover 24 reaches the outer peripheral side surface of the first opening 22a.
  • an annular protrusion 24c is formed on the inner peripheral side surface of the cover 24.
  • the inner diameter of the cover 24 is equal to or slightly smaller than the outer diameter of the large diameter portion 23a.
  • the inner diameter of the annular protrusion 24c is equal to or slightly smaller than the outer diameter of the small diameter portion 23b. Yes.
  • the front end surface 24d of the annular protrusion 24c is in contact with the outer peripheral side surface of the small diameter portion 23b, and the side surface 24e of the annular protrusion 24c is in contact with the step portion 23c between the large diameter portion 23a and the small diameter portion 23b.
  • a plurality of steps 24f are formed on the outer peripheral side surface of the cover 24 so that the cover 24 can be easily removed together with the first plug 23 so that it can be easily gripped.
  • a sample collection container according to another embodiment of the present invention is shown in a front view in FIG. 8 and a front sectional view in FIG.
  • the sample collection container 31 shown in FIGS. 8 and 9 is the same as the sample collection container 1 described above except that the shape of the second stopper fitted in the second opening is different. It is configured.
  • a second plug 32 is fitted in the second opening 2b so as to hermetically seal the inside.
  • the second plug 32 has a large diameter portion 32a having a truncated cone shape and a small diameter portion 32b.
  • the large diameter portion 32a has a larger diameter than the small diameter portion 32b.
  • the large diameter portion 32a has a diameter larger than the outer diameter of the container body.
  • a recess 32c is provided in the center of the outer surface of the second plug 32, and a recess is formed in the center of the inner surface of the second plug 32.
  • 32d is provided.
  • the small diameter portion 32b is press-fitted into the second opening 2b, and the second opening 2b is hermetically sealed by the second plug 32.
  • the second stopper 32 When the second stopper 32 is configured to be pierced by a blood collection needle or syringe as in the present embodiment, the second internal space A2 is separated after blood is separated. Plasma or serum contained in the can be easily collected using a blood collection needle or syringe. Therefore, since it is not necessary to remove the second plug 32 when taking out the plasma or serum, it is possible to prevent the plasma or serum from overflowing from the second opening 2b.
  • FIGS. 1-10 A sample collection container according to still another embodiment of the present invention is shown in front sectional views in FIGS.
  • the sample collection container 41 shown in FIG. 10 and the sample collection container 51 shown in FIG. 11 are configured in the same manner as the sample collection container 1 described above except that the arrangement part or material of the flow path closing member is different. It is made.
  • the flow path closing member 42 is composed of a mixture of a resin that swells when it comes into contact with plasma or serum and a thermoplastic resin.
  • a hole 42a is formed at the center of the channel closing member 42 so as to secure a channel through which plasma or serum flows in the initial state, that is, before swelling.
  • the channel closing member swells when contacted with plasma or serum It is composed of a mixture of resin and thermoplastic resin.
  • the sample collection container 51 has a cylindrical container body 52 having a first opening 52a on one end side and a second opening 52b on the other end side.
  • An annular protrusion 52 c is provided on the inner peripheral surface of the container body 52.
  • the distal end portion of the annular protrusion 52c also has a molded body force of a resin that swells when it comes into contact with plasma or blood, and constitutes a flow path closing member 52d. That is, the opening 52e surrounded by the flow path closing member 52d constitutes a hollow flow path.
  • the annular protrusion 52c on the inner peripheral surface of the container main body 52 is provided with a taper 52f toward the flow path closing member 52d side.
  • FIGS. 12 (a) and 12 (b) are a front view and a front sectional view of a sample collection container according to still another embodiment of the present invention provided with a blood diffusion material.
  • a first opening 62a is provided at one end of the container body 62, and a second opening 62b is provided at the other end.
  • the container main body 62 has a first internal space A1 on the first opening 62a side and a second internal space A2 on the second opening 62b side.
  • the first opening 62 a is hermetically closed by the first plug 63
  • the second opening 62 b is hermetically closed by the second plug 64.
  • a cover 65 configured in the same manner as the cover 5 is provided outside the second plug 64.
  • the first plug 63 is provided with a recess 63c that opens outward. By providing the recess 63c, the central portion of the first plug 63 is thin. It is fleshed and the puncture resistance by the blood collection needle mentioned later is lowered.
  • the first plug 63 has a relatively small diameter portion 63b and a relatively large diameter portion 63a provided at the tip.
  • the second plug body 64 is configured in the same manner as the second plug body 4 described above, the corresponding parts will be denoted by the corresponding reference numerals and the description thereof will be omitted.
  • the cover 65 is also configured in the same manner as the cover 5, so that the corresponding parts are denoted by the corresponding reference numerals and the description thereof is omitted.
  • the blood separation filter 6 is disposed on the first opening 62a side, that is, in the first inner space A1.
  • a blood cell stop filter 8 is disposed after the blood separation filter 6!
  • the blood separation filter 6 and the blood cell stop filter 8 are configured in the same manner as the blood separation filter 6 and the blood cell stop filter 8 of the embodiment shown in FIG.
  • a feature of the present embodiment is that a blood diffusion material 67 is disposed in the front stage of the blood separation filter 6, that is, on the first opening 62a side.
  • the blood diffusion material 7 is disposed between the first plug 63 and the blood separation filter 6 so that the blood supplied with the force of the first opening 62a is brought into contact with the blood separation filter 6 earlier.
  • the blood diffusion material 67 is disposed so as to contact the blood separation filter 6.
  • the blood diffusion material 67 can be composed of various materials and is not particularly limited. For example, polyethylene, polypropylene, polyethylene terephthalate,
  • It can be formed from a constituent resin such as polybutylene terephthalate, polystyrene, polyvinyl acetate, urethane resin, acrylic resin, semi-synthetic fiber such as rayon, or glass fiber.
  • a constituent resin such as polybutylene terephthalate, polystyrene, polyvinyl acetate, urethane resin, acrylic resin, semi-synthetic fiber such as rayon, or glass fiber.
  • the blood diffusion material 67 preferably has a plurality of holes in order to diffuse blood in various directions.
  • the diameter of the blood diffusing material is preferably in the range of 15 to 2000 111, more preferably in the range of 20 to LOOO / zm.
  • the pore diameter is in the range of 15 to 2000 / ⁇ ⁇ , blood diffuses more effectively in the blood diffusion material 6 in multiple directions.
  • the porosity of the blood diffusion material formed by a plurality of pores is preferably in the range of 50 to 97%, more preferably in the range of 60 to 95%.
  • the porosity is in the range of 50 to 97%, the blood diffusion material Within 67, blood diffuses more effectively in multiple directions.
  • a flow path blocking member 7 is disposed in the subsequent stage of the blood cell stop filter 8.
  • the channel closing member 7 has the same hole 7a as the channel closing member 7 of the embodiment shown in FIG.
  • the blood diffusing material 67, the blood separation filter 6, and the blood cell stop filter 8 are disposed in the first internal space A1, and the flow path blocking member 7 is connected to the first internal space A1 and the second internal space A1. It is placed between space A2.
  • FIGS. FIG. 13 to FIG. 16 show a step-by-step process until blood is separated into blood cells and plasma or serum, and the separated plasma or serum is taken out.
  • Fig. 13 shows a state before a syringe from which blood has been collected is inserted into the sample collection container 61
  • Fig. 14 shows a syringe force from which blood has been collected. Inject blood into the sample collection container 61! / The state of the middle stage is shown in front sectional view.
  • Fig. 15 shows the state after the separated plasma or serum is stored in the internal space
  • Fig. 16 shows the state when the separated plasma or serum is taken out from the specimen collection container 1 in a front sectional view.
  • . 13 to 15 show the specimen collection container 61 in a state where the state shown in FIG. 12 is turned upside down.
  • the specimen collection container 61 when separating blood, is arranged so that the first opening 62a is on the upper side and the second opening 62b is on the lower side.
  • a hub 73 that can be airtightly fitted to the concave portion 63c of the first plug 63 described above is provided.
  • the hub 73 restricts the insertion distance of the hollow needle 72 into the first plug 63. That is, when the syringe 71 is inserted into the first stopper 63, the needle tip 72a does not reach the blood separation filter 6 and the needle tip 72a can be inserted into the blood diffusion material 7. It is configured as follows.
  • the blood is preferably flowed into the blood diffusion material 67.
  • the blood diffusing material 67 When blood flows directly into the blood diffusing material 67, it is possible to prevent blood cells from colliding with the blood diffusing material 67 at a high speed when the blood flows in and destroying the blood cells.
  • the blood fluid that has flowed into the blood diffusion material 67 diffuses in multiple directions within the blood diffusion material 67. Accordingly, the blood diffused in multiple directions in the blood diffusion material 67 flows into the entire surface 6a of the blood separation filter 6 on the first opening 62a side.
  • plasma or serum is separated from the blood in the same manner as in the embodiment shown in FIG. 1, and the separated plasma is separated in the second internal space A2.
  • serum can be removed.
  • a sample collection container according to still another embodiment of the present invention is shown in a front view in FIG. 17 (a) and in a front sectional view in FIG. 17 (b).
  • the sample collection container 81 shown in Figs. 17 (a) and 17 (b) is different except that the shape of the first opening and the shape of the first stopper provided in the first opening are different.
  • the configuration is the same as that of the sample collection container 61 described above.
  • components that are configured in the same manner as the sample collection container 61 are denoted by the same reference numerals and description thereof is omitted.
  • the sample collection container 81 has a cylindrical container body 82 having a first opening 82a on one end side and a second opening 82b on the other end side.
  • the first opening 82a and the second opening 82b have the same opening diameter.
  • An annular protrusion 82c is provided on the inner peripheral surface of the container body 82 between the flow path closing member 8 and the second internal space A2.
  • the annular protrusion 82c forms an opening 82d surrounded by the annular protrusion 82c, and constitutes a hollow flow path.
  • a taper 82e is attached to the annular protrusion 82c on the inner peripheral surface of the container body 82 toward the first opening 82a.
  • a first plug 83 is attached to the first opening 82a so as to hermetically seal the inside.
  • the first plug 83 has a large diameter part 83a and a small diameter part 83b.
  • Large diameter part 83a is small diameter part 83b Have a larger diameter.
  • the large diameter portion 83a has a diameter larger than the outer diameter of the container body.
  • a hemispherical recess 83c is provided in the center of the outer surface of the first stopper 83.
  • the small diameter portion 83b is press-fitted into the first opening 82a, and the first opening 82a is hermetically sealed by the first plug 83.
  • the second opening 82 b is hermetically sealed using the second plug 64 whose outer surface is covered by the cover 65, and the inside of the sample collection container 81 is decompressed. .
  • the outer surface of the first plug 83 is covered with a cover 84.
  • the cover 84 is provided with a hole 84a in the concave portion 83c of the first plug 83 so that the first plug 83 is pierced by a blood collection needle or syringe. /!
  • the cover 84 extends further upward from the outer peripheral side surface of the large-diameter portion 83a, and the upper end 84b of the cover 84 reaches the outer peripheral side surface of the first opening 82a.
  • an annular protrusion 84c is formed on the inner peripheral side surface of the cover 84.
  • the inner diameter of the cover 84 is equal to or slightly smaller than the outer diameter of the large diameter portion 83a.
  • the inner diameter of the annular projection 84c is equal to or slightly smaller than the outer diameter of the small diameter portion 83b. Yes.
  • the tip end surface 84d of the annular protrusion 84c is in contact with the outer peripheral side surface of the small diameter portion 83b, and the side surface 84e of the annular protrusion 84c is in contact with the step portion 83c between the large diameter portion 83a and the small diameter portion 83b.
  • a plurality of steps 84f are formed on the outer peripheral side surface of the cover 84 so that the cover 84 can be easily removed together with the first plug 83 so that it can be easily gripped.
  • the first opening 82a has the above-described shape, and the first plug 83 having the outer surface covered by the cover 24 is attached to the first opening 82a.
  • the blood collection needle can be easily inserted and removed from the first plug 83 while holding the container body 82 and the cover 84 with fingers. Further, it is easy to remove the cover 84 together with the first plug 83. Furthermore, after separating the blood, it is easy to erect the sample collection container 81 so that the first opening 82a is on the lower side and the second opening 82b is on the upper side.
  • a specimen collection container according to still another embodiment of the present invention is shown in a front view in FIG. 18 (a) and in a front sectional view in FIG. 18 (b).
  • the specimen collection container 91 shown in Figs. 18 (a) and 18 (b) is the same as the specimen collection container described above except that the shape of the second stopper attached to the second opening is different. Constructed like 61! ⁇ The
  • a second plug 92 is attached to the second opening 62b so as to hermetically seal the inside.
  • the second plug 92 has a large-diameter portion 92a having a truncated cone shape and a small-diameter portion 92b.
  • the large diameter portion 92a has a larger diameter than the small diameter portion 92b.
  • the large diameter portion 92a has a diameter larger than the outer diameter of the container body.
  • a recess 92c is provided in the center of the outer surface of the second stopper 92, and a recess 92d is provided in the center of the inner surface of the second stopper 92. Is provided.
  • the small diameter portion 92b is press-fitted into the second opening 62b, and the second opening 62b is hermetically sealed by the second plug 92.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Clinical Laboratory Science (AREA)
  • Ecology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

It is intended to provide a container for sampling a specimen which can separate blood into blood cells and the plasma or the serum within a short period of time and can surely prevent the thus separated plasma or serum from the contamination with intraerythrocytic components, and from which the separated plasma or serum can be easily taken out by a laboratory technician without suffering from infection with a pathogen. A container (1) for sampling a specimen comprising a tubular container (2) having a first opening (2a) in the side of one end and a second opening (2b) in the side of the other end, and first and second stoppers (3) and (4) setting respectively in the first and second openings (2a) and (2b), wherein a blood-separating filter (6) for separating the sampled blood into blood cell components and the plasma or the serum is further provided between the first inner space (A1), which is located in the side of the first opening (2a) and into which the blood is sampled, and the second inner space, which is located in the side of the second opening (2b) and in which the plasma or the serum separated form the blood is contained.

Description

明 細 書  Specification
検体採取容器  Sample collection container
技術分野  Technical field
[0001] 本発明は、血液から血漿若しくは血清を分離し、該血漿若しくは血清中の成分を検 查するのに用いられる検体採取容器に関し、より詳細には、分離された血漿若しくは 血清が、赤血球力も漏洩してきた成分により汚染されるのを確実に防ぐことができ、か つ分離された血漿若しくは血清を容易に取出すことができる検体採取容器に関する 背景技術  The present invention relates to a specimen collection container used for separating plasma or serum from blood and examining components in the plasma or serum, and more specifically, the separated plasma or serum is red blood cells. Background art on a sample collection container that can reliably prevent contamination by components that have leaked power and can easily extract separated plasma or serum
[0002] 従来、血液から血球成分を除去し、臨床検査に必要な血漿または血清を得るため に、遠心分離法が用いられてきた。しかし、遠心分離法では、凝固過程や分離後に 上澄みの血漿または血清を移し力える過程などの作業が煩雑であった。また、検査 結果を得るまでに時間を要し、さらに大型で高価な遠心分離機が必要であった。  Conventionally, centrifugation has been used to remove blood cell components from blood and obtain plasma or serum necessary for clinical examination. However, in the centrifugation method, the work such as the coagulation process and the process of transferring the supernatant plasma or serum after separation is complicated. Moreover, it took time to obtain the test results, and a larger and more expensive centrifuge was required.
[0003] この問題を解決するために、遠心分離機を用いることなぐ血液から血球成分を除 去し、臨床検査に必要な血漿または血清を得ることを可能とする様々な器具が提案 されている。  [0003] In order to solve this problem, various instruments have been proposed that can remove blood cell components from blood without using a centrifuge and obtain plasma or serum necessary for clinical examination. .
[0004] 下記特許文献 1には、採取された血液から、血漿もしくは血清を分離し、分離され た血漿または血清を取出すことを可能とする血液検査用容器の一例が開示されてい る。図 19を参照して、特許文献 1に示されている血液検査用容器を説明する。  [0004] Patent Document 1 below discloses an example of a blood test container that makes it possible to separate plasma or serum from collected blood and to take out the separated plasma or serum. With reference to FIG. 19, the blood test container shown in Patent Document 1 will be described.
[0005] 図 19に縦断面図で示すように、血液検査用容器 101は、外管 102と、筒状部材 10 3と、栓体 104とを有する気密容器であり、内部が減圧されている。外管 102内に、筒 状部材 103が挿入されている。外管 102は、有底の管状容器で構成されており、外 管 102は上端に開口 102aを有する。  [0005] As shown in a longitudinal sectional view in FIG. 19, a blood test container 101 is an airtight container having an outer tube 102, a cylindrical member 103, and a stopper 104, and the inside is decompressed. . A cylindrical member 103 is inserted into the outer tube 102. The outer tube 102 is a bottomed tubular container, and the outer tube 102 has an opening 102a at the upper end.
[0006] 他方、筒状部材 103は、上端に開口 103aを有する。また、筒状部材 103の下方部 分には、フィルタ 105が収納されている。フィルタ 105は、フィルタ部材 106と、フィル タ部材 106の下方に配置された血球停止膜 107とを有する。フィルタ部材 106は、血 球成分よりも血漿または血清を速く移動させるフィルタ材料により構成されている。血 球停止膜 107は、血球を捕捉し、分離された血漿または血清への血球の混入を防止 するために設けられている。 [0006] On the other hand, the cylindrical member 103 has an opening 103a at its upper end. A filter 105 is housed in the lower part of the cylindrical member 103. The filter 105 includes a filter member 106 and a blood cell stop film 107 disposed below the filter member 106. The filter member 106 is made of a filter material that moves plasma or serum faster than blood cell components. blood The sphere stop membrane 107 is provided for capturing blood cells and preventing the blood cells from being mixed into the separated plasma or serum.
[0007] 筒状部材 103の下端には、下方に突出された突出部 103bが形成されている。突 出部 103bには血漿または血清流路 108が設けられている。血漿または血清流路 10 8は、血球停止膜 107の下面に対向しており、かつ突出部 103b内を下方に延びるよ うに設けられている。フィルタ部材 106により分離された血漿または血清は、血漿また は血清流路 108から下方の血漿または血清収納部 109に流下される。なお、フィル タ部材 105の上方の空間は、血液収容部 110を構成している。  [0007] At the lower end of the cylindrical member 103, a protruding portion 103b protruding downward is formed. A plasma or serum channel 108 is provided in the protruding portion 103b. The plasma or serum channel 108 is opposed to the lower surface of the blood cell stop film 107 and is provided so as to extend downward in the protrusion 103b. The plasma or serum separated by the filter member 106 flows down from the plasma or serum channel 108 to the lower plasma or serum container 109. Note that the space above the filter member 105 constitutes a blood storage unit 110.
[0008] 栓体 104は、把持部 104aと、大径部 104bと、小径部 104cとを有する。大径部 10 4bは、小径部 104cよりも大きな径を有する。小径部 104cが筒状部材 103の開口 10 3aに圧入されており、大径部 104bが外管 102の開口 102aに圧入されている。  [0008] The plug 104 has a gripping portion 104a, a large diameter portion 104b, and a small diameter portion 104c. The large diameter portion 104b has a larger diameter than the small diameter portion 104c. The small diameter portion 104c is press-fitted into the opening 103a of the cylindrical member 103, and the large diameter portion 104b is press-fitted into the opening 102a of the outer tube 102.
[0009] 上記血液検査用容器 101の使用に際しては、栓体 104に採血針を刺通することに より、内外の圧力差により血液を血液収容部 110に採取する。採取された血液は、フ ィルタ 105によって濾過される。上述したように、フィルタ部材 106では、血漿または 血清が血球成分よりも速やかに下方に移動する。そして、血漿または血清は、血球 停止膜 107を通過し、血漿または血清流路 108に至る。しかる後、血漿または血清 は、血漿または血清収納部 109に流下される。他方、血球は血球停止膜 107により 捕捉される。血球により血球停止膜 107が閉塞されると、濾過が停止する。  When the blood test container 101 is used, blood is collected in the blood storage section 110 by a pressure difference between the inside and outside by inserting a blood collection needle through the plug 104. The collected blood is filtered by the filter 105. As described above, in the filter member 106, plasma or serum moves downward more rapidly than the blood cell component. Then, plasma or serum passes through the blood cell stop membrane 107 and reaches the plasma or serum channel 108. Thereafter, the plasma or serum flows down to the plasma or serum storage unit 109. On the other hand, blood cells are captured by the blood cell stop film 107. Filtration stops when the blood cell stop membrane 107 is blocked by blood cells.
[0010] 血漿または血清が分離された後には、外管 102の開口 102aに圧入されている栓 体 104を筒状部材 103ごと抜去する。このようにして、分離された血漿または血清を 取出すことができる。  [0010] After the plasma or serum is separated, the plug member 104 pressed into the opening 102a of the outer tube 102 is removed together with the tubular member 103. In this way, the separated plasma or serum can be removed.
特許文献 1 :特開 2004— 325412号公報  Patent Document 1: Japanese Unexamined Patent Application Publication No. 2004-325412
発明の開示  Disclosure of the invention
[0011] 上記特許文献 1に記載の血液検査用容器 101では、血球停止膜 107に血球が捕 捉されて、血球停止膜 107が閉塞されて濾過が停止する。しカゝしながら、濾過が終了 した後長時間放置された場合には、血球停止膜 107に捕捉されている赤血球が破 壊し、赤血球内成分が漏洩することがある。漏洩した赤血球内成分は、血漿または血 清流路 108に一且貯留される力 一部が血漿または血清収納部 109に流下し、血漿 または血清に赤血球内成分が混入するおそれがあった。 [0011] In blood test container 101 described in Patent Document 1, blood cells are captured by blood cell stop film 107, blood cell stop film 107 is blocked, and filtration stops. However, if the filter is left for a long time after the filtration is completed, the red blood cells captured by the blood cell arresting membrane 107 may be destroyed and the components in the red blood cells may leak. The leaked erythrocyte component is partly stored in the plasma or serum flow path 108. Or there was a possibility that components in erythrocytes might be mixed in serum.
[0012] さらに、分離された血漿または血清を取出す際には、外管 102から筒状部材 103ご と栓体 104を抜去しなければならな力つた。外管 102から栓体 104を筒状部材 103ご と抜去する際には、筒状部材 103に振動が加わりがちであった。そのため、血球停止 膜 107に捕捉されている赤血球が破壊されて赤血球内成分が漏洩し、血漿または血 清に赤血球内成分が混入しがちであった。カロえて、筒状部材 103に振動が加わると 、血漿または血清流路 108に貯留されている赤血球内成分が、血漿または血清収納 部 109に流下するおそれがあった。  [0012] Further, when taking out the separated plasma or serum, it was necessary to remove the tubular member 103 and the plug 104 from the outer tube 102. When the plug 104 is removed from the outer tube 102 with the cylindrical member 103, vibration tends to be applied to the cylindrical member 103. For this reason, the red blood cells captured by the blood cell stop membrane 107 were destroyed, and the components in the red blood cells leaked, and the components in the red blood cells tended to be mixed into plasma or serum. If the cylindrical member 103 is vibrated, the components in the erythrocytes stored in the plasma or serum channel 108 may flow down to the plasma or serum storage unit 109.
また、血液を流入させる際に血液検査用容器 101内の減圧度が高いと、採血針の 針先力 血液が高速で流入することがあった。血液が高速で流入すると、フィルタ部 材 106に血球が高速で衝突し、血球が破壊されることがあった。血球が破壊されて赤 血球内成分が漏洩すると、血漿または血清収納部 109に収容されている血漿または 血清に赤血球内成分が混入する。この場合、得られた血漿または血清を検査すると 、混入した赤血球内成分が検査結果に大きく影響し、信頼性の高い検査結果を得る ことができな力 た。  In addition, if the degree of decompression in blood test container 101 is high when blood is allowed to flow in, blood at the tip of the blood collection needle may flow at high speed. When blood flowed in at high speed, the blood cells collided with the filter member 106 at high speed, and the blood cells could be destroyed. When blood cells are destroyed and components in red blood cells leak, the components in red blood cells are mixed into plasma or serum stored in plasma or serum storage unit 109. In this case, when the obtained plasma or serum was examined, the contaminated erythrocyte component greatly affected the test result, and it was impossible to obtain a highly reliable test result.
[0013] 血球が破壊されるのを防止するためには、血液検査用容器 101の減圧度を低くす る必要があった。し力しながら、減圧度が低すぎると、血液の分離の途中で濾過が停 止することがあり、必要量の血漿または血清が得られないことがあった。  [0013] In order to prevent blood cells from being destroyed, it was necessary to reduce the degree of decompression of the blood test container 101. However, if the degree of vacuum is too low, filtration may stop during blood separation, and the required amount of plasma or serum may not be obtained.
[0014] また、血液収容部 110に血液が残っている場合には、筒状部材 103を抜去すると、 その際の振動等により濾過が再開されて、抜去された筒状部材 103から血漿や血清 が流下することがあった。  [0014] If blood remains in blood storage section 110, when tubular member 103 is removed, filtration is resumed due to vibration or the like at that time, and plasma or serum is removed from removed tubular member 103. Sometimes flowed down.
[0015] さらに、外管 102から栓体 104を抜去するには、検査技師などが手作業で抜去する 必要があった。外管 102から栓体 104を手作業により抜去する場合には、検査技師 の手や腕に血漿または血清が流下し、検査技師が血液中の病原体に感染するおそ れがあった。  [0015] Furthermore, in order to remove the plug 104 from the outer tube 102, an inspection engineer or the like had to be removed manually. When the plug 104 was manually removed from the outer tube 102, plasma or serum flowed down to the hands and arms of the laboratory technician, and the laboratory technician could be infected with pathogens in the blood.
発明の概要  Summary of the Invention
[0016] 本発明の目的は、上述した従来技術の現状に鑑み、短時間で血液を血球成分と 血漿または血清とに分離することができ、分離された血漿若しくは血清が、赤血球か ら漏洩してきた成分により汚染されるのを確実に防ぐことができ、かつ検査技師が病 原体に感染することなぐ分離された血漿若しくは血清を容易に取出すことができる 検体採取容器を提供することにある。 [0016] In view of the state of the prior art described above, an object of the present invention is to separate blood into blood cell components and plasma or serum in a short time, and whether the separated plasma or serum is red blood cells. To provide a sample collection container that can reliably prevent contamination by leaked components, and can easily remove the separated plasma or serum without infecting the pathogen by a laboratory technician It is in.
[0017] 本発明に係る検体採取容器は、血液から血漿若しくは血清を分離し、該血漿若しく は血清中の成分を検査するのに用!ヽられる検体採取容器であって、一端側に第 1の 開口を有し、他端側に第 2の開口を有する筒状の容器本体と、第 1の開口に嵌合さ れている第 1の栓体と、第 2の開口に嵌合されている第 2の栓体とを備え、筒状の容 器本体が、第 1の開口側に血液が採取される第 1の内部空間と、第 2の開口側に血 液力 分離された血漿若しくは血清が収容される第 2の内部空間とを有し、第 1,第 2 の内部空間の間に配置されており、第 1の内部空間に採取された血液を血球成分と 血漿若しくは血清とに分離するための血液分離フィルタをさらに備えることを特徴とす る。  [0017] A sample collection container according to the present invention is a sample collection container used for separating plasma or serum from blood and examining components of the plasma or serum. A cylindrical container body having an opening of 1 and a second opening on the other end side, a first stopper fitted in the first opening, and a second opening. A cylindrical container body having a first internal space in which blood is collected on the first opening side and blood-pressure separated plasma on the second opening side Or a second internal space in which serum is accommodated, and is disposed between the first and second internal spaces, and blood collected in the first internal space is converted into a blood cell component and plasma or serum. And a blood separation filter for separating the blood.
[0018] 本発明に係る検体採取容器のある特定の局面では、前記第 1の開口側から供給さ れた血液が前記血液分離フィルタよりも先に接触されるように前記第 1の栓体と前記 血液分離フィルタとの間に配置されており、かっ血液を内部で様々な方向に拡散さ せつつ通過させて血液を前記血液分離フィルタに流入させる血液拡散材がさらに備 えられている。  [0018] In a specific aspect of the sample collection container according to the present invention, the first stopper and the first stopper so that blood supplied from the first opening side is contacted before the blood separation filter. There is further provided a blood diffusing material that is disposed between the blood separation filter and allows blood to flow through the blood separation filter while allowing the blood to pass through while being diffused in various directions.
[0019] 本発明の他の特定の局面では、検体採取容器は、血液分離フィルタと前記第 2の 内部空間との間に配置されており、前記血液分離フィルタにより分離された血球成分 の通過を防止する血球停止フィルタをさらに備えている。この場合には、血液の分離 の際に、血球停止フィルタにより血球の通過が確実に防止されて、赤血球や白血球 の血漿または血清への混入をより一層確実に防止することができる。  [0019] In another specific aspect of the present invention, the specimen collection container is disposed between a blood separation filter and the second internal space, and allows passage of blood cell components separated by the blood separation filter. A blood cell stop filter for preventing the blood cell is further provided. In this case, the blood cell can be reliably prevented from passing by the blood cell stop filter when blood is separated, and contamination of red blood cells or white blood cells into plasma or serum can be prevented more reliably.
[0020] 本発明のさらに他の特定の局面では、検体採取容器は、血液分離フィルタと第 2の 内部空間との間に配置されており、血液分離フィルタにより分離された血漿若しくは 血清に接触されることにより膨潤し、流路を閉塞する流路閉塞部材をさらに備えてい る。この場合には、分離された血漿若しくは血清が第 2の内部空間に収容された後に は、流路閉塞部材の血漿若しくは血清との接触による膨潤によって流路が閉塞され る。 よって、上記移動速度差により血漿若しくは血清よりも遅れて血球成分が流路閉塞 部材に至った際には、流路が閉塞されているため、第 2の内部空間に収容された血 漿若しくは血清に血球が混入するのを防止することができる。さらに、血液を分離した 後に長時間放置されて、赤血球内成分が漏洩した場合でも、流路が閉塞されている ため、血漿若しくは血清に、赤血球内成分が混入するのを防止することができる。 血液を分離した後に、第 2の内部空間に収容されて 、る血漿若しくは血清を取出 す際には、第 1の開口が下方側に、第 2の開口が上方側となるように検体採取容器を 配置した後に、第 2の開口力 第 2の栓体を抜去すればよい。流路が流路閉塞部材 により閉塞されて 、るため、第 2の内部空間に収容されて 、る血漿若しくは血清が、 血液分離フィルタや第 1の内部空間に至ることがない。従って、血漿若しくは血清が 血球または赤血球内成分と接触し難いので、血漿若しくは血清の汚染を防止するこ とができる。よって、第 2の開口から、汚染されていない血漿若しくは血清を、容易に かつ確実に取出すことができる。また、分離された血漿または血清などに接触されて 、検査技師などが血液中の病原体に感染することもより一層確実に防ぐことができる [0020] In still another specific aspect of the present invention, the specimen collection container is disposed between the blood separation filter and the second internal space, and is brought into contact with plasma or serum separated by the blood separation filter. And a flow path closing member that swells and closes the flow path. In this case, after the separated plasma or serum is accommodated in the second internal space, the flow path is closed by swelling of the flow path closing member due to contact with plasma or serum. Therefore, when the blood cell component reaches the flow path blocking member later than the plasma or serum due to the difference in the moving speed, the flow path is closed, so that the plasma or serum stored in the second internal space is blocked. It is possible to prevent blood cells from being mixed in. Furthermore, even when the blood component is left for a long time after separation and the components in the red blood cells leak, the flow channel is blocked, so that the components in the red blood cells can be prevented from being mixed into the plasma or serum. After removing the blood, when taking out the plasma or serum contained in the second internal space, the sample collection container is such that the first opening is on the lower side and the second opening is on the upper side. After the arrangement, the second opening force and the second plug may be removed. Since the flow path is closed by the flow path closing member, the plasma or serum contained in the second internal space does not reach the blood separation filter or the first internal space. Therefore, since plasma or serum is difficult to come into contact with blood cells or erythrocyte components, contamination of plasma or serum can be prevented. Therefore, uncontaminated plasma or serum can be easily and reliably removed from the second opening. In addition, it is possible to more reliably prevent laboratory technicians from being infected with pathogens in the blood by contact with the separated plasma or serum.
[0021] 本発明のさらに他の特定の局面では、流路閉塞部材は、血球停止フィルタと第 2の 内部空間との間に配置されている。この場合には、血球停止フィルタと第 2の内部空 間との間の流路が閉塞されるため、第 2の内部空間に収容されている血漿若しくは血 清を取出す際に、第 1の開口が下方側に、第 2の開口が上方側となるように検体採取 容器を配置しても血球停止フィルタに血漿もしくは血清が至ることがない。よって、血 球停止フィルタに捕捉されて ヽる赤血球や白血球の血漿または血清への混入をより 一層確実に防ぐことができる。 [0021] In still another specific aspect of the present invention, the flow path blocking member is disposed between the blood cell stop filter and the second internal space. In this case, since the flow path between the blood cell stop filter and the second internal space is blocked, the first opening is removed when taking out the plasma or serum contained in the second internal space. Even if the sample collection container is placed so that the second opening is on the lower side and the second opening is on the upper side, plasma or serum does not reach the hemocytosis filter. Therefore, it is possible to more reliably prevent the red blood cells and white blood cells trapped by the blood cell stop filter from being mixed into the plasma or serum.
[0022] 本発明に係る検体採取容器のさらに他の特定の局面では、第 2の栓体の外表面は 、第 2の栓体が採血針またはシリンジにより刺通されるのを防止するカバーにより覆わ れている。この場合には、誤って第 2の栓体に採血針またはシリンジが刺通され、第 2 の内部空間に血液が採取されるのを防止することができる。  [0022] In still another specific aspect of the specimen collection container according to the present invention, the outer surface of the second stopper is covered with a cover that prevents the second stopper from being pierced by a blood collection needle or syringe. Covered. In this case, it is possible to prevent blood from being collected in the second internal space by accidentally inserting a blood collection needle or syringe into the second stopper.
[0023] 本発明に係る検体採取容器の別の特定の局面では、筒状の容器本体の内周面に 、第 1の開口側に向ってテーパーが付けられている。この場合には、第 2の内部空間 に収容されている血漿若しくは血清の量が少ない場合であっても液面が高くなり、液 面が第 2の開口に近くなるため、血漿若しくは血清をより一層容易に取出すことが可 能となる。 In another specific aspect of the sample collection container according to the present invention, the inner peripheral surface of the cylindrical container body is tapered toward the first opening side. In this case, the second internal space Even when the amount of plasma or serum contained in the container is small, the liquid level becomes high and the liquid level becomes close to the second opening, so that it is possible to more easily remove plasma or serum. .
本発明に係る検体採取容器では、好ましくは、前記第 1,第 2の栓体が、前記容器 本体の第 1,第 2の開口に気密的に取り付けられており、前記容器本体内が減圧され ている。この場合には、内部が減圧されているので、圧力差により、血液から血漿もし くは血清を速やかに分離することができる。  In the sample collection container according to the present invention, preferably, the first and second stoppers are airtightly attached to the first and second openings of the container body, and the inside of the container body is decompressed. ing. In this case, since the inside is depressurized, plasma or serum can be rapidly separated from blood by the pressure difference.
(発明の効果)  (The invention's effect)
[0024] 本発明に係る検体採取容器では、筒状の容器本体は一端側に第 1の開口を、他端 側に第 2の開口を有する。第 1の開口側の第 1の内部空間と、第 2の開口側の第 2の 内部空間との間に、第 1の内部空間に採取された血液を血球成分と血漿若しくは血 清とに分離するための血液分離フィルタが配置されているので、血液の分離の際に は、血液分離フィルタにおいて血球成分と、血漿若しくは血清との移動速度差を利 用し、血液を血球成分と血漿若しくは血清とに分離することができる。  [0024] In the sample collecting container according to the present invention, the cylindrical container body has a first opening on one end side and a second opening on the other end side. The blood collected in the first internal space is separated into a blood cell component and plasma or serum between the first internal space on the first opening side and the second internal space on the second opening side. Therefore, when separating blood, the blood separation filter uses the difference in moving speed between blood cell components and plasma or serum, and blood is separated from blood cell components and plasma or serum. And can be separated.
[0025] 血液が血球成分と血漿若しくは血清とに分離されて、血漿もしくは血清が第 2の内 部空間に収容された後には、例えば第 2の開口に嵌合されている第 2の栓体に例え ば採血針やシリンジなどを刺通して、若しくは第 2の開口に嵌合されている第 2の栓 体を抜去して、第 2の内部空間に収容されて 、る血漿または血清を容易に取出すこ とがでさる。  [0025] After the blood is separated into a blood cell component and plasma or serum and the plasma or serum is accommodated in the second internal space, for example, the second plug fitted in the second opening For example, a blood collection needle or a syringe is pierced, or the second plug fitted in the second opening is removed, and the plasma or serum contained in the second internal space can be easily removed. It can be taken out.
[0026] 第 2の栓体に例えば採血針やシリンジなどを刺通して血漿または血清を取出すこと により、検査技師などが血漿または血清などに接触され難くなり、検査技師などが血 液中の病原体に感染することを防ぐことができる。  [0026] By removing the plasma or serum from the second plug by inserting a blood collection needle or a syringe, for example, it becomes difficult for the laboratory technician or the like to come into contact with the plasma or serum. Can prevent infection.
上記血液拡散材がさらに備えられている場合には、血液拡散材内で血液が多方向 に拡散されて、血液が血液分離材に至る。すなわち、本発明の検体採取容器では、 血液が採取されるときに、血球が血液分離材に直接衝突することが防がれており、か つ血液が多方向に拡散されて血液分離材に流入するため、血球が破壊され難ぐ赤 血球内成分に汚染されて 、な 、血漿または血清を得ることができる。  When the blood diffusion material is further provided, blood is diffused in multiple directions in the blood diffusion material, and the blood reaches the blood separation material. That is, in the sample collection container of the present invention, when blood is collected, the blood cells are prevented from directly colliding with the blood separation material, and the blood is diffused in multiple directions and flows into the blood separation material. Therefore, plasma or serum can be obtained without being contaminated with red blood cell components that are difficult to destroy.
図面の簡単な説明 [図 1]図 1は、本発明の一実施形態に係る検体採取容器を示す正面図である。 Brief Description of Drawings FIG. 1 is a front view showing a sample collection container according to an embodiment of the present invention.
[図 2]図 2は本発明の一実施形態に係る検体採取容器を示す正面断面図である。  FIG. 2 is a front sectional view showing a sample collection container according to one embodiment of the present invention.
[図 3]図 3は本発明の一実施形態に係る検体採取容器に血液を採取した直後の状態 を示す正面断面図である。 FIG. 3 is a front cross-sectional view showing a state immediately after blood is collected in a sample collection container according to an embodiment of the present invention.
[図 4]図 4は本発明の一実施形態に係る検体採取容器に採取された血液が分離され ている途中段階の状態を示す正面断面図である。  FIG. 4 is a front cross-sectional view showing a state in the middle of the stage where blood collected in the sample collection container according to one embodiment of the present invention is separated.
[図 5]図 5は本発明の一実施形態に係る検体採取容器から、分離された血色若しくは 血清を取出す際の状態を示す正面断面図である。  FIG. 5 is a front sectional view showing a state in which separated blood color or serum is taken out from a sample collection container according to one embodiment of the present invention.
[図 6]図 6は本発明の他の実施形態に係る検体採取容器を示す正面図である。  FIG. 6 is a front view showing a sample collection container according to another embodiment of the present invention.
[図 7]図 7は本発明の他の実施形態に係る検体採取容器を示す正面断面図である。 FIG. 7 is a front sectional view showing a sample collection container according to another embodiment of the present invention.
[図 8]図 8は本発明の別の実施形態に係る検体採取容器を示す正面図である。 FIG. 8 is a front view showing a sample collection container according to another embodiment of the present invention.
[図 9]図 9は本発明の別の実施形態に係る検体採取容器を示す正面断面図である。 FIG. 9 is a front cross-sectional view showing a sample collection container according to another embodiment of the present invention.
[図 10]図 10は本発明のさらに別の実施形態に係る検体採取容器を示す正面断面図 である。 FIG. 10 is a front sectional view showing a sample collection container according to still another embodiment of the present invention.
[図 11]図 11は本発明のさらに別の実施形態に係る検体採取容器を示す正面断面図 である。  FIG. 11 is a front sectional view showing a sample collection container according to still another embodiment of the present invention.
[図 12]図 12は (a)及び (b)は、本発明のさらに他の実施形態に係る検体採取容器を 示す正面図および正面断面図である。  FIG. 12 (a) and (b) are a front view and a front sectional view showing a sample collection container according to still another embodiment of the present invention.
[図 13]図 13は本発明のさらに他の実施形態に係る検体採取容器の使用方法を説明 するための図であり、血液が採取されたシリンジを検体採取容器内に刺通する前の 状態を示す正面断面図である。  FIG. 13 is a view for explaining a method of using a sample collection container according to still another embodiment of the present invention, and shows a state before a syringe from which blood has been collected is pierced into the sample collection container FIG.
[図 14]図 14は本発明のさらに他の実施形態に係る検体採取容器の使用方法を説明 するための図であり、血液が採取されたシリンジ力 検体採取容器内に血液を流入さ せている途中段階の状態を示す正面断面図である。  FIG. 14 is a diagram for explaining a method of using a sample collection container according to still another embodiment of the present invention. The syringe force from which blood is collected is allowed to flow into the sample collection container. It is front sectional drawing which shows the state in the middle stage.
[図 15]図 15は本発明のさらに他の実施形態に係る検体採取容器の使用方法を説明 するための図であり、分離された血漿または血清が内部空間に収容された後の状態 を示す正面断面図である。  FIG. 15 is a view for explaining a method of using a sample collection container according to still another embodiment of the present invention, and shows a state after separated plasma or serum is accommodated in the internal space. It is front sectional drawing.
[図 16]図 16は本発明のさらに他の実施形態に係る検体採取容器の使用方法を説明 するための図であり、検体採取容器力 分離された血漿または血清を取出すときの 状態を示す正面断面図である。 [FIG. 16] FIG. 16 illustrates a method of using a specimen collection container according to still another embodiment of the present invention. FIG. 5 is a front sectional view showing a state when the separated plasma or serum is taken out.
[図 17]図 17は (a)及び (b)は、本発明の別の実施形態に係る検体採取容器を示す 正面図および正面断面図である。  FIG. 17 is a front view and a front sectional view showing a specimen collection container according to another embodiment of the present invention.
[図 18]図 18は (a)及び (b)は、本発明の別の実施形態に係る検体採取容器を示す 正面図および正面断面図である。  FIG. 18 (a) and (b) are a front view and a front sectional view showing a sample collection container according to another embodiment of the present invention.
[図 19]図 19は従来の検体採取容器の一例を示す正面断面図である。  FIG. 19 is a front sectional view showing an example of a conventional specimen collection container.
符号の説明 Explanation of symbols
1…検体採取容器  1 ... Sample collection container
2…容器本体  2 ... Body body
2a, 2b…第 1,第 2の開口  2a, 2b ... 1st and 2nd openings
2c…環状突部  2c ... Annular protrusion
2d…開口部  2d… Opening
2e…テーパー  2e… Taper
3…第 1の栓体  3 ... 1st plug
3a…大径部  3a… large diameter part
3b…小径部  3b ... Small diameter part
3c…凹部  3c ... recess
4…第 2の栓体  4… Second plug
4a…大径部  4a… large diameter part
4b…小径部  4b ... Small diameter part
4c…段差部分  4c… Step part
5· · ·カバー  5 ··· Cover
5a…下端  5a ... Bottom
5b…環状突部  5b… Annular protrusion
5c…先端面  5c… Tip surface
5d…側面  5d ... side
5e…段差 …血液分離フィルタ …流路閉塞部材 …血球停止フィルタ1…採血針5e… Step … Blood separation filter… Flow path blocking member… Blood cell stop filter 1… Blood collection needle
1…検体採取容器1 ... Sample collection container
2…容器本体2 ... Body body
2a, 22b…第 1,第 2の開口2c…環状突部2a, 22b ... 1st and 2nd opening 2c ... Annular projection
2d…開口部2d… Opening
2e…テーパー2e… Taper
3···第 1の栓体3 ... 1st plug
a…大径部 a… Large diameter part
b…小径部 b ... Small diameter part
c…凹部 c ... concave
···カバー ···cover
a…孑し a ... sushi
b…上端 b… Upper end
c…環状突部 c ... annular protrusion
d…先端面 d… Tip surface
e…側面 e ... side
f…段差  f ... Step
…検体採取容器 ... Sample collection container
···第 2の栓体 .... Second plug
a…大径部 a… Large diameter part
b…小径部 b ... Small diameter part
c, 32d…凹部  c, 32d ... recess
…検体採取容器 42· ··流路閉塞部材 ... Sample collection container 42 ...
42a…孑し  42a ...
51…検体採取容器  51 ... Sample collection container
52· ··容器本体  52 ··· Container body
52a, 52b…第 1,第 2の開口  52a, 52b ... 1st and 2nd openings
52c…環状突部  52c… Annular protrusion
52d…流路閉塞部材  52d: Channel block member
52e…開口部  52e… Opening
52f…テーパー  52f… Taper
61…検体採取容器  61 ... Sample collection container
62· ··容器本体  62 ··· Container body
62a, 62b…第 1,第 2の開口  62a, 62b ... 1st and 2nd openings
67…血液拡散材  67… Blood diffusion material
A1, Α2· ··第 1,第 2の内部空間  A1, Α2 ... the first and second internal spaces
発明を実施するための最良の形態  BEST MODE FOR CARRYING OUT THE INVENTION
[0029] 以下、本発明の詳細を説明する。 [0029] Details of the present invention will be described below.
[0030] (筒状の容器本体) [0030] (tubular container body)
本発明に係る検体採取容器に用いられる筒状の容器本体は、一端側に第 1の開口 を有し、反対側端部である他端側に第 2の開口を有し、第 1の開口側に第 1の内部空 間を、第 2の開口側に第 2の内部空間を有する。筒状の容器本体の形状としては、特 に限定されず、角筒状、円筒状などの形状が挙げられる。  The cylindrical container body used for the sample collection container according to the present invention has a first opening on one end side and a second opening on the other end side which is the opposite end, and the first opening A first internal space is provided on the side, and a second internal space is provided on the second opening side. The shape of the cylindrical container body is not particularly limited, and examples thereof include a rectangular tube shape and a cylindrical shape.
[0031] 筒状の容器本体の素材としては、空気非透過性を有するものであれば特に限定さ れない。容器本体の素材としては、例えばポリエチレンテレフタレート等の合成樹脂 が挙げられる。容器本体が合成樹脂からなる場合には、表面に金属や珪素などが蒸 着されて、空気非透過性能が向上されていてもよい。 [0031] The material of the cylindrical container body is not particularly limited as long as it has air impermeability. Examples of the material for the container body include synthetic resins such as polyethylene terephthalate. When the container body is made of a synthetic resin, the air non-permeation performance may be improved by vapor deposition of metal or silicon on the surface.
[0032] 容器本体の大きさ ·形状は特に限定されな 、が、一般的な臨床検査機器のラック適 合性を考慮すると、例えば外径 16mm X長さ 100mm迄の大きさ、略円筒状の形状 が挙げられる。 [0033] (第 1の栓体) [0032] The size and shape of the container body are not particularly limited. However, considering the rack compatibility of general clinical laboratory equipment, for example, the outer diameter is 16mm x the length is up to 100mm. Shape. [0033] (first plug)
第 1の栓体は、空気非透過性を有し、かつ採血針またはシリンジにより刺通され得 る素材により構成されていればよぐその素材は特に限定されない。第 1の栓体を構 成する素材としては、例えば天然ゴム、ブチルゴム、イソプレンゴム、または熱可塑性 エラストマ一等の弾性体が挙げられる。  The first plug is not particularly limited as long as it is made of a material that is impermeable to air and can be pierced by a blood collection needle or syringe. Examples of the material constituting the first plug body include elastic bodies such as natural rubber, butyl rubber, isoprene rubber, or thermoplastic elastomer.
[0034] (第 2の栓体)  [0034] (second plug)
第 2の栓体は、空気非透過性を有する素材により構成されていればよぐその素材 は特に限定されない。第 2の栓体を構成する素材としては、例えば天然ゴム、ブチル ゴム、イソプレンゴム、または熱可塑性エラストマ一等の弾性体が挙げられる。  The second plug is not particularly limited as long as it is made of an air impermeable material. Examples of the material constituting the second plug body include elastic bodies such as natural rubber, butyl rubber, isoprene rubber, and thermoplastic elastomer.
[0035] 第 2の栓体の外表面は、例えば金属、合成樹脂等力 なるカバーにより覆われてい ることが好ま U、。採血針またはシリンジにより刺通されな 、カバーが設けられて!/、る 場合には、誤って第 2の栓体に採血針またはシリンジが刺通され、第 2の内部空間に 血液が採取されるのを防止することができる。カバーを構成する素材としては、特に 限定されないが、例えばポリプロピレン、ポリエチレン、ポリエチレンテレフタレート、ポ リカーボネート等が挙げられる。  [0035] It is preferable that the outer surface of the second plug is covered with a cover made of metal, synthetic resin or the like. If the cover is provided without being pierced by the blood collection needle or syringe, the blood collection needle or syringe is accidentally pierced by the second stopper, and blood is collected in the second internal space. Can be prevented. The material constituting the cover is not particularly limited, and examples thereof include polypropylene, polyethylene, polyethylene terephthalate, and polycarbonate.
[0036] (血液分離フィルタ)  [0036] (Blood separation filter)
本発明に用いられる血液分離フィルタとしては、例えば、極細繊維の集積体、連続 した気泡を有する発泡体または焼結体、中空糸膜、多孔質膜、多孔性粒子、複数溝 および Zまたは孔を有するフィルムなどがあげられる力 血流が通過するに際して実 質的に血液を血球と血漿または血清に分離できるものであれば、上記の例示に限定 されるものではではない。また、血球成分をフィルタの内部で捕捉することで分離して も良いし、血球成分と血漿または血清成分の移動速度差によって分離してもよい。  Examples of the blood separation filter used in the present invention include an assembly of ultrafine fibers, a foam or sintered body having continuous bubbles, a hollow fiber membrane, a porous membrane, porous particles, a plurality of grooves and Z or pores. The force that the film can have is not limited to the above examples as long as blood can be substantially separated into blood cells and plasma or serum when the blood flow passes. Further, the blood cell component may be separated by being captured inside the filter, or may be separated by the difference in the moving speed between the blood cell component and the plasma or serum component.
[0037] また血液分離フィルタは非対称フィルタと対称フィルタに分けることができる。非対 称フィルタとはここでは血液の流入側から流出側にかけて血液が流れる孔の孔径が 小さくなるような構造を有するフィルタを総称する。それ以外の血液分離フィルタを対 称フィルタと総称する。  [0037] The blood separation filter can be divided into an asymmetric filter and a symmetric filter. Here, the asymmetric filter is a general term for a filter having a structure in which the diameter of a hole through which blood flows from the inflow side to the outflow side becomes small. Other blood separation filters are collectively referred to as symmetric filters.
[0038] これらの血液分離フィルタのうち血液が流れる多数の孔を有する対称フィルタとして は、血液が流れる孔の平均孔径が 1 μ m以上、 10 μ m以下の範囲のものが好ましい。 さらに好ましくは 2 /z m以上、 8 /z m以下の範囲である。平均孔径が 1 mより小さいと 、溶血することがあり、 10 mより大きくなると、血球と血漿もしくは血清との分離が著 しく悪くなるおそれがある。 [0038] Of these blood separation filters, the symmetrical filter having a number of holes through which blood flows preferably has an average pore diameter of 1 μm or more and 10 μm or less. More preferably, it is in the range of 2 / zm or more and 8 / zm or less. If the average pore size is less than 1 m, hemolysis may occur, and if it exceeds 10 m, separation of blood cells from plasma or serum may be significantly worsened.
[0039] また、血液分離フィルタのうち血液が流れる多数の孔を有する非対称フィルタとして は、血液が流れる孔の平均孔径が 0. 01 μ m以上、 10 μ m以下の範囲のものが好ま しい。さらに好ましくは 0. 1 μ m以上、 6 μ m以下である。平均孔径カ ^Ο. 01 μ mより/ Jヽ さいと、血球成分が目詰まりを起こし分離できなくなること、または溶血することがあり 、平均孔径が 10 mより大きくなると血球と血漿もしくは血清との分離が著しく悪くな るおそれがある。 [0039] Further, among the blood separation filters, as the asymmetric filter having a large number of holes through which blood flows, an average pore diameter of the holes through which blood flows is preferably 0.01 μm or more and 10 μm or less. More preferably, it is 0.1 μm or more and 6 μm or less. Average pore size ^ Ο. From 01 μm / J ヽ If the mean pore size is larger than 10 m, blood cell components may become clogged and may not be separated. Separation may be significantly worse.
[0040] 血液分離フィルタが極細繊維の集積体からなる場合には平均繊維径が 0. 5〜3. 0 μ mの範囲にある繊維体が集積されて形成されていることが好ましい。平均繊維径 が 0. より小さいと、血液を分離する際に溶血を起こし易くなる。平均繊維径が 3 . 0 mより大きいと、血球と血漿または血清とを分離するために、血液分離フィルタ を高密度に形成する必要があり、また使用する繊維の量も多くなりコストが高くなる。 血液の分離効果をより一層高めるためには、平均繊維径は、 0. 5〜2. の範囲 にあることがより好ましい。  [0040] When the blood separation filter is composed of an aggregate of ultrafine fibers, it is preferable that fiber bodies having an average fiber diameter in the range of 0.5 to 3.0 µm are accumulated. If the average fiber diameter is smaller than 0, hemolysis is likely to occur when blood is separated. If the average fiber diameter is larger than 3.0 m, it is necessary to form a blood separation filter at a high density in order to separate blood cells from plasma or serum, and the amount of fibers used increases and the cost increases. . In order to further enhance the blood separation effect, the average fiber diameter is more preferably in the range of 0.5 to 2.
[0041] 容器本体内に設置されたときの血液分離フィルタの平均密度は、 0. 1〜0. 5g/c m3の範囲であることが好ましい。平均密度が 0. lg/cm3より低い場合には、血液の 分離が効果的に行えないことがあり、得られる血漿若しくは血清の量が少なくなること がある。平均密度が、 0. 5g/cm3より高い場合には、赤血球への負荷が大きくなり、 溶血を起こし易くなる。血液をより一層効率的に分離するためには、平均密度は 0. 1 5〜0. 40gZcm3の範囲にあることが好ましい。 [0041] The average density of the blood separation filter when installed in the container body is preferably in the range of 0. 1~0. 5g / cm 3. If the average density is lower than 0.1 lg / cm 3 , blood separation may not be performed effectively, and the amount of plasma or serum obtained may be reduced. When the average density is higher than 0.5 g / cm 3 , the load on red blood cells is increased, and hemolysis is likely to occur. In order to separate blood more efficiently, the average density is preferably in the range of 0.15 to 0.40 gZcm 3 .
[0042] なお血液分離フィルタとして前記対称フィルタと非対称フィルタとを組み合わせて使 用することも可能である。  [0042] It is also possible to use the symmetric filter and the asymmetric filter in combination as a blood separation filter.
[0043] 血液分離フィルタは、血液中の成分を吸着する性質を有して 、てもよ 、。この場合 には、血液中の成分の吸着を抑制または制御するために血液分離フィルタに表面処 理が施されていてもよい。表面処理剤としては、特に限定されないが、ポリエーテル 系、シリコーン系等の潤滑剤、ポリビュルアルコールまたはポリビュルピロリドン等の 親水性高分子類、さらには天然の親水性高分子類、高分子界面活性剤等が挙げら れる。また、血液分離フィルタの表面は、酸化剤による化学処理、プラズマ処理など により親水化処理がされていてもよい。また逆に、疎水シリコーン、フッ素系表面処理 剤に様に撥水処理がされていても良い。 [0043] The blood separation filter may have a property of adsorbing components in blood. In this case, the blood separation filter may be subjected to a surface treatment in order to suppress or control the adsorption of components in the blood. The surface treatment agent is not particularly limited, but may be a polyether-based or silicone-based lubricant, such as polybulal alcohol or polybulurpyrrolidone. Examples thereof include hydrophilic polymers, natural hydrophilic polymers, and polymer surfactants. Further, the surface of the blood separation filter may be hydrophilized by chemical treatment with an oxidizing agent, plasma treatment, or the like. Conversely, water repellent treatment may be applied as in hydrophobic silicone and fluorine surface treatment agents.
[0044] (血球停止フィルタ)  [0044] (Blood cell stop filter)
本発明では、血液分離フィルタと第 2の内部空間との間に、赤血球の通過を防止で きる血球停止フィルタが配置されて 、ることが好まし 、。  In the present invention, it is preferable that a blood cell stop filter capable of preventing passage of red blood cells is disposed between the blood separation filter and the second internal space.
[0045] 血球停止フィルタは赤血球の通過を防止できればよぐその材質は特に限定されな い。材質としては、例えば、ポリビ-リデンジフルオライド、ポリテトラフルォロエチレン 、酢酸セルロース、ニトロセルロース、ポリカーボネート、ポリエチレンテレフタレート、 ポリエチレン、ポリプロピレン、ガラスファイバー、ポロシリケート、塩ィ匕ビュルまたは銀 等を挙げることができる。  [0045] The material of the blood cell stopping filter is not particularly limited as long as it can prevent passage of red blood cells. Examples of the material include polyvinylidene difluoride, polytetrafluoroethylene, cellulose acetate, nitrocellulose, polycarbonate, polyethylene terephthalate, polyethylene, polypropylene, glass fiber, polysilicate, salt butyl, silver, and the like. be able to.
[0046] 血球停止フィルタは、好ましくは、赤血球の通過を防止する孔を有する、多孔質物 質力もなる。血球停止フィルタが多孔質物質を用いて構成されている場合には、血 漿若しくは血清の通過は可能である。血球停止フィルタを構成する多孔質物質として は、赤血球の通過を防止できる範囲の孔径を有するものであれば、特に限定されず 、多数の一貫通孔がー方面から多方面に至っている多孔質膜や、様々な多孔質材 料が用いられ得る。赤血球の通過を防止するためには、孔径は 1 m以下であること が好ましい。孔径が小さすぎると、血液中のタンパク成分などにより目詰まりを起こす 可能性があるため、孔径は 0. 01 m以上であることが好ましい。赤血球の通過を効 果的に防止するためには、孔径は 0. 05 /z m以上、 以下の範囲にあることがよ り好ましい。  [0046] The blood cell stop filter preferably also has a porous material force having pores that prevent passage of red blood cells. If the hemostasis filter is constructed using a porous material, plasma or serum can pass through. The porous substance constituting the blood cell stopping filter is not particularly limited as long as it has a pore diameter in a range that can prevent passage of red blood cells, and a porous membrane in which a number of through-holes extend from one side to many sides. In addition, various porous materials can be used. In order to prevent passage of red blood cells, the pore size is preferably 1 m or less. If the pore size is too small, clogging may occur due to protein components in the blood. Therefore, the pore size is preferably 0.01 m or more. In order to effectively prevent the passage of erythrocytes, the pore diameter is more preferably in the range of 0.05 / zm to the following.
[0047] 濾過の流速を高めるために、血球停止フィルタの表面は親水処理されて!、てもよ!/ヽ 。親水処理の方法としては、プラズマ処理、親水性高分子によるコーティング等が挙 げられる力 これらの方法に限定されず、他の方法を用いてもよい。  [0047] In order to increase the flow rate of filtration, the surface of the blood cell stop filter may be hydrophilically treated! The method of hydrophilic treatment is a force that includes plasma treatment, coating with a hydrophilic polymer, etc. The method is not limited to these methods, and other methods may be used.
[0048] (流路閉塞部材)  [0048] (Flow path blocking member)
本発明では流路に、血漿若しくは血清に接触されることにより膨潤する流路閉塞部 材が配置されていることが好ましい。流路閉塞部材は、血液分離フィルタと第 2の内 部空間との間に配置されていることが好ましぐ血液停止フィルタと第 2の内部空間と の間に配置されて 、ることがより好ま U、。 In the present invention, it is preferable that a channel closing member that swells when contacted with plasma or serum is disposed in the channel. The flow path blocking member includes a blood separation filter and a second inner member. U, which is preferably disposed between the blood stop filter and the second internal space, is preferably disposed between the subspace.
[0049] 本発明に用いられる流路閉塞部材の素材としては、特に限定されないが、分子骨 格に親水性の官能基を有し、自重に対し同量以上の水を吸収できる性質を有する榭 脂が好適である。流路閉塞部材の素材の具体例としては、ポリアクリル酸アルカリ金 属塩系榭脂またはその共重合体およびそれらの架橋体、ポリアクリルアミド系榭脂ま たはその共重合体およびそれらの架橋体、ポリ N—ビュルァセトアミド系榭脂または その共重合体およびそれらの架橋体、シリコン系榭脂またはその共重合体およびそ れらの架橋体、ポリビニルエーテル系榭脂およびその共重合体およびそれら架橋体 、ポリアルキレンオキサイド系榭脂またはその共重合体およびそれらの架橋体、ポリビ -ルアルコール、ポリビニルピロリドンまたはその共重合体およびそれらの架橋体等 が挙げられる。 [0049] The material of the flow path blocking member used in the present invention is not particularly limited, but has a hydrophilic functional group in the molecular skeleton and has the property of absorbing the same amount or more of water with respect to its own weight. Fat is preferred. Specific examples of the material of the flow path blocking member include poly (alkali acrylate) metal salt-based resins or copolymers thereof and their crosslinked products, polyacrylamide-based resins or their copolymers and their crosslinked products. , Poly-N-bulucetamide-based resins or copolymers thereof and cross-linked products thereof, silicon-based resins or copolymers thereof and cross-linked products thereof, polyvinyl ether-based resins and copolymers thereof, and These cross-linked products include polyalkylene oxide-based resins or copolymers thereof and cross-linked products thereof, polyvinyl alcohol, polyvinyl pyrrolidone or copolymers thereof and cross-linked products thereof.
[0050] 流路閉塞部材としては、粉末状、粒状としたものを用いてもよぐフィルムやシート状 に成形したものを用いてもよい。流路閉塞部材がシート状に成形されていると、流路 に設置することが容易となる。流路閉塞部材としては、ペースト状、スラリー状または 溶液等にしたものを用いてもよぐこれを添加し乾燥させるなどしてもよい。  [0050] As the flow path blocking member, a powder or granular material may be used, or a film or sheet shaped material may be used. If the channel closing member is formed into a sheet shape, it can be easily installed in the channel. As the channel closing member, a paste, slurry, solution or the like may be used, which may be added and dried.
[0051] 流路閉塞部材は、血漿若しくは血清に接触されることでそれ自身が膨潤し、流路を 閉塞させる。そのため、流路閉塞部材の必要量は、閉塞させる流路体積、流路閉塞 部材の膨潤率及び膨潤速度によって異なる。よって、閉塞させる流路体積、流路閉 塞部材の膨潤率及び膨潤速度から、流路閉塞部材の最適な量が計算される。  [0051] The flow path closing member swells itself by being in contact with plasma or serum, and closes the flow path. Therefore, the required amount of the flow path closing member varies depending on the flow path volume to be closed, the swelling rate and the swelling speed of the flow path closing member. Therefore, the optimum amount of the channel closing member is calculated from the channel volume to be closed, the swelling rate and the swelling speed of the channel closing member.
[0052] 閉塞させる流路体積は、血液中の水分が吸収されかつ検体の回収量が低下しない 範囲で設定される。流路体積が大きくなると、閉塞させるための流路閉塞部材の量も 多くなるため、検体の回収量が低下するおそれがある。  [0052] The channel volume to be occluded is set in a range in which moisture in the blood is absorbed and the collected amount of the sample does not decrease. When the volume of the channel is increased, the amount of the channel closing member for blocking is increased, so that the amount of collected sample may be reduced.
[0053] 従って、閉塞させる流路体積は、 0. 005〜1. Ocm3の範囲にあることが好ましい。 Therefore, it is preferable that the channel volume to be closed is in the range of 0.005 to 1. Ocm 3 .
また、流路閉塞部材の体積は閉塞させる流路体積に対し、 5〜95%の範囲にあるこ とが好ましい。流路閉塞部材の体積が閉塞させる流路体積に対し 5%より小さいと、 流路を閉塞するまでの時間が長くなるため、赤血球から漏洩してきた成分が、分離し た血漿もしくは血清に混入するおそれがある。流路閉塞部材の体積が閉塞させる流 路体積に対し 95%より大きいと、血漿若しくは血清がすべて回収される前に流路が 閉塞されてしまうことがあり、血漿若しくは血清の回収効率が低下するおそれがある。 Further, the volume of the flow path closing member is preferably in the range of 5 to 95% with respect to the volume of the flow path to be closed. If the volume of the flow path blocking member is less than 5% of the volume of the flow path to be blocked, the time until the flow path is closed becomes longer, so components leaking from red blood cells are mixed into the separated plasma or serum. There is a fear. Flow blocked by the volume of the flow path blocking member If the volume is larger than 95%, the flow path may be blocked before all plasma or serum is collected, which may reduce the collection efficiency of plasma or serum.
[0054] (検体採取容器内の圧力) [0054] (Pressure in specimen collection container)
本発明では、空気非透過性の第 1,第 2の栓体により容器本体内の気密性を確保 して、真空検体採取容器とすることが好ましい。  In the present invention, it is preferable to secure a gas tightness in the container main body by the first and second air-impermeable plugs to obtain a vacuum specimen collection container.
[0055] 検体採取容器内の圧力は、血液の濾過の駆動力を発揮し、かっ血球成分に対す る負荷による赤血球の破壊を防止するために、 10〜90kPaの範囲にあることが好ま しぐより好ましくは 30〜80kPaの範囲である。圧力が 90kPaより高いと、血液の分離 に長時間を要することがあり、圧力が lOkPaより低いと、赤血球が破壊されて赤血球 内成分が漏洩し易くなる。 [0055] The pressure in the specimen collection container is preferably in the range of 10 to 90 kPa in order to exert the driving force of blood filtration and prevent the destruction of red blood cells due to the load on the blood cell components. More preferably, it is the range of 30-80kPa. If the pressure is higher than 90 kPa, it may take a long time to separate the blood. If the pressure is lower than lOkPa, the red blood cells are destroyed and the components in the red blood cells are likely to leak.
[0056] 以下、本発明の具体的な実施形態を説明することにより本発明を明らかにする。 Hereinafter, the present invention will be clarified by describing specific embodiments of the present invention.
[0057] 図 1〜5を用いて、本発明の一実施形態に係る検体採取容器を説明する。 [0057] A sample collection container according to an embodiment of the present invention will be described with reference to Figs.
[0058] 本発明の一実施形態に係る検体採取容器を、図 1に正面図、図 2に正面断面図で 示す。 [0058] A sample collection container according to an embodiment of the present invention is shown in a front view in FIG. 1 and a front sectional view in FIG.
[0059] 図 1及び図 2に示すように、検体採取容器 1は、一端側に第 1の開口 2aを有し、他 端側に第 2の開口 2bを有する円筒状の容器本体 2を有する。容器本体 2の第 1の 0 開口 2の側の端部は逆円錐台形状の先細りした形状を有し、第 1の開口 2aの開口径 が第 2の開口 2bの開口径よりも小さくされている。なお、図 1及び図 2では、第 1の開 口 2aが下方側、第 2の開口 2bが上方側となるように検体採取容器 1が図示されてい る。  [0059] As shown in FIGS. 1 and 2, the sample collection container 1 has a cylindrical container body 2 having a first opening 2a on one end side and a second opening 2b on the other end side. . The end of the container body 2 on the first 0 opening 2 side has a tapered shape of an inverted frustoconical shape, and the opening diameter of the first opening 2a is made smaller than the opening diameter of the second opening 2b. Yes. 1 and 2, the sample collection container 1 is shown so that the first opening 2a is on the lower side and the second opening 2b is on the upper side.
[0060] 第 1の開口 2aには、内部を気密封止するように第 1の栓体 3が嵌合されている。第 1 の栓体 3は、大径部 3aと、小径部 3bとを有する。大径部 3aは、小径部 3bよりも大きな 径を有する。採血針またはシリンジによる刺通を容易とするために、第 1の栓体の外 側表面の中央には、逆円錐台形状の凹部 3cが設けられて、第 1の栓体の中央が薄 肉化されている。小径部 3bが第 1の開口 2aに圧入されており、それによつて、第 1の 栓体 3により第 1の開口 2aが気密封止されている。  [0060] The first plug 2 is fitted in the first opening 2a so as to hermetically seal the inside. The first plug 3 has a large diameter portion 3a and a small diameter portion 3b. The large diameter portion 3a has a larger diameter than the small diameter portion 3b. In order to facilitate piercing with a blood collection needle or syringe, an inverted frustoconical recess 3c is provided in the center of the outer surface of the first stopper, and the center of the first stopper is thin. It has become. The small diameter portion 3b is press-fitted into the first opening 2a, whereby the first opening 2a is hermetically sealed by the first plug body 3.
[0061] 他方、第 2の開口 2bには、着脱可能に第 2の栓体 4が嵌合されている。第 2の栓体 4は、大径部 4aと、小径部 4bとを有する。大径部 4aは、小径部 4bよりも大きな径を有 する。大径部 4aは、容器本体 2の外径よりも大きな径を有する。小径部 4bが第 2の開 口 2bに圧入されており、第 2の栓体 4により第 2の開口 2bが気密封止されている。な お、検体採取容器 1内は減圧されている。 On the other hand, the second plug 4 is detachably fitted in the second opening 2b. The second plug 4 has a large diameter part 4a and a small diameter part 4b. The large diameter part 4a has a larger diameter than the small diameter part 4b. To do. The large diameter portion 4a has a diameter larger than the outer diameter of the container body 2. The small diameter portion 4b is press-fitted into the second opening 2b, and the second opening 2b is hermetically sealed by the second plug body 4. The inside of the sample collection container 1 is depressurized.
[0062] 第 2の栓体 4が採血針またはシリンジにより誤って刺通されるのを防止するために、 第 2の栓体 4の外表面はカバー 5により覆われている。本実施形態では、大径部 4aの 外表面全体がカバー 5により覆われている。カバー 5は大径部 4aの外周側面からさら に下方に延ばされており、カバー 5の下端 5aは第 2の開口 2bの外周側面に至ってい る。カバー 5の内周側面には、環状突部 5bが形成されている。カバー 5の内径は大 径部 4aの外径と等 、か若しくはわず力〖こ小さくされて 、るが、環状突部 5b部分に おける内径は、小径部 4bの外径と等しいか若しくはわずかに小さくされている。すな わち、環状突部 5bの先端面 5cが小径部 4bの外周側面と当接されており、環状突部 5bの側面 5dが、大径部 4aと小径部 4bとの段差部分 4cに当接されている。他方、容 易に把持し得るように、さらに第 2の栓体 4ごとカバー 5を容易に抜去し得るように、力 バー 5の外周側面には複数の段差 5eが形成されている。  [0062] The outer surface of the second plug 4 is covered with a cover 5 in order to prevent the second plug 4 from being accidentally pierced by a blood collection needle or syringe. In the present embodiment, the entire outer surface of the large diameter portion 4a is covered with the cover 5. The cover 5 extends further downward from the outer peripheral side surface of the large diameter portion 4a, and the lower end 5a of the cover 5 reaches the outer peripheral side surface of the second opening 2b. On the inner peripheral side surface of the cover 5, an annular protrusion 5b is formed. The inner diameter of the cover 5 is equal to or slightly smaller than the outer diameter of the large diameter portion 4a. However, the inner diameter of the annular protrusion 5b is equal to or slightly smaller than the outer diameter of the small diameter portion 4b. Has been made smaller. In other words, the front end surface 5c of the annular protrusion 5b is in contact with the outer peripheral side surface of the small diameter portion 4b, and the side surface 5d of the annular protrusion 5b contacts the step portion 4c between the large diameter portion 4a and the small diameter portion 4b. It is in contact. On the other hand, a plurality of steps 5e are formed on the outer peripheral side surface of the force bar 5 so that the cover 5 can be easily removed together with the second plug 4 so that it can be easily grasped.
[0063] 図 1及び図 2に示すように、容器本体 2では、第 1の開口 2a側に血液が採取される 第 1の内部空間 A1が配置されており、第 2の開口 2b側に血液から分離された血漿若 しくは血清が収容される第 2の内部空間 A2が配置されている。後に詳述するが、第 1 の内部空間 A1は、血液が採取される部分であり、第 2の内部空間 A2は、分離された 血漿若しくは血清が収容され、取出される部分である。  [0063] As shown in Figs. 1 and 2, in the container body 2, a first internal space A1 in which blood is collected is disposed on the first opening 2a side, and blood is disposed on the second opening 2b side. A second internal space A2 for accommodating plasma or serum separated from the blood is disposed. As will be described in detail later, the first internal space A1 is a part from which blood is collected, and the second internal space A2 is a part from which separated plasma or serum is stored and taken out.
[0064] 第 1の内部空間 A1内には、第 1の内部空間 A1に採取された血液を血球成分と血 漿若しくは血清とに分離するための血液分離フィルタ 6が配置されて 、る。血液分離 フィルタ 6と第 2の内部空間 A2との間には、血液分離フィルタ 6により分離された血漿 若しくは血清に接触されることにより膨潤する樹脂からなる円盤状の流路閉塞部材 7 が配置されている。初期状態、すなわち膨潤前には血漿若しくは血清が流れる流路 を確保するように、流路閉塞部材 7の中央に孔 7aが形成されて 、る。  In the first internal space A1, a blood separation filter 6 for separating blood collected in the first internal space A1 into a blood cell component and plasma or serum is arranged. Between the blood separation filter 6 and the second internal space A2, a disc-shaped flow path blocking member 7 made of a resin that swells when contacted with plasma or serum separated by the blood separation filter 6 is disposed. ing. In the initial state, that is, before swelling, a hole 7a is formed in the center of the channel closing member 7 so as to secure a channel through which plasma or serum flows.
[0065] 本実施形態では、流路閉塞部材 7と第 2の内部空間 A2との間において、容器本体 2の内周面に、環状突部 2cが設けられている。この環状突部 2cにより、該環状突部 2 cに囲まれた開口部 2dが形成されており、中空流路を構成している。上述した流路閉 塞部材 7の孔 7aは開口部 2dに連ねられている。容器本体 2の内周面の環状突部 2c には、流路閉塞部材 7側に向ってテーパー 2eが付けられている。 In the present embodiment, an annular protrusion 2c is provided on the inner peripheral surface of the container body 2 between the flow path closing member 7 and the second internal space A2. The annular protrusion 2c forms an opening 2d surrounded by the annular protrusion 2c, and constitutes a hollow channel. Closed flow path as described above The hole 7a of the blocking member 7 is connected to the opening 2d. A taper 2e is attached to the annular protrusion 2c on the inner peripheral surface of the container body 2 toward the flow path closing member 7 side.
[0066] 血液分離フィルタ 6と流路閉塞部材 7との間には、血液分離フィルタ 6により分離さ れた血球の通過を防止する円盤状の血球停止フィルタ 8が配置されて 、る。血球停 止フィルタ 8は、血液分離フィルタ 6と当接されており、かつ流路閉塞部材 7と一定間 隔を隔てられている。 [0066] Between the blood separation filter 6 and the flow path blocking member 7, a disc-shaped blood cell stop filter 8 that prevents passage of blood cells separated by the blood separation filter 6 is disposed. The blood cell stop filter 8 is in contact with the blood separation filter 6 and is spaced apart from the flow path blocking member 7 by a certain distance.
[0067] 図 3〜図 5を用いて、上述した本実施形態に係る検体採取容器 1の使用方法を以 下説明する。  [0067] A method of using the specimen collection container 1 according to this embodiment described above will be described below with reference to FIGS.
[0068] 図 3に、検体採容器 1に血液を採取した直後の状態、図 4に、検体採取容器 1に採 取された血液が分離されている途中段階の状態、図 5に、分離された血漿若しくは血 清を検体採取容器 1から取出す際の状態が、それぞれ正面断面図で示されている。  [0068] FIG. 3 shows a state immediately after blood is collected in the specimen collection container 1, FIG. 4 shows a state in the middle of separation of the blood collected in the specimen collection container 1, and FIG. The state of taking out the plasma or serum from the sample collection container 1 is shown in a front sectional view.
[0069] 図 3及び図 4に、検体採取容器 1を図 1及び 2に示す状態と上下が逆にされた状態 で示す。図 3及び図 4に示すように、血液を採取 ·分離する際には、第 1の開口 2aが 上方側、第 2の開口 2bが下方側となるように検体採取容器 1を配置する。  [0069] FIGS. 3 and 4 show the sample collection container 1 in the state shown in FIGS. 1 and 2 upside down. As shown in FIGS. 3 and 4, when collecting and separating blood, the sample collection container 1 is arranged so that the first opening 2a is on the upper side and the second opening 2b is on the lower side.
[0070] 図 3に示すように、血液を第 1の内部空間に導入するために、第 1の栓体 2aに採血 針 11を刺入する。検体採取容器 1内が減圧されて!、るので血液が採血針 11から第 1 の内部空間 A1に導かれ、また、血液分離フィルタ 6に至る。血液を導入した後に、採 血針を抜去する。  As shown in FIG. 3, a blood collection needle 11 is inserted into the first stopper 2a in order to introduce blood into the first internal space. The sample collection container 1 is depressurized! Therefore, blood is guided from the blood collection needle 11 to the first internal space A1, and also reaches the blood separation filter 6. After blood is introduced, the blood collection needle is removed.
[0071] なお、血液の採取に際しては、採血ホルダーに検体採取容器 1に装着して直接採 血針を用いて真空採血してもよいし、ー且シリンジに血液を採取した後にシリンジの 針を第 1の栓体 3に刺入し、血液を導いてもよい。血液を採取した後には、採血針もし くはシリンジの針は好ましくは上記のように抜去される力 第 1の栓体 3に刺入された ままでもよ 、。  [0071] When collecting blood, the sample collection container 1 may be attached to a blood collection holder and vacuum collected using a blood collection needle directly, or after collecting blood into a syringe, the syringe needle may be removed. The first plug 3 may be inserted to guide blood. After the blood is collected, the blood collection needle or syringe needle is preferably removed as described above. The first stopper 3 may remain inserted.
[0072] 図 4に示すように、第 1の内部空間 A1に供給された血液は血液分離フィルタ 6を通 過する。血液分離フィルタ 6では、血液が通過する際に、血球成分よりも血漿若しくは 血清が速く移動する。相対的に速く移動した血漿若しくは血清は、血球停止フィルタ 8に先に達し、該血球停止フィルタ 8を通過する。そして、血漿若しくは血清は、流路 閉塞部材 7の孔 7aを通過し、容器本体 2の開口部 2dの中空流路から流下して第 2の 内部空間 A2に収容される。 As shown in FIG. 4, the blood supplied to the first internal space A 1 passes through the blood separation filter 6. In the blood separation filter 6, when blood passes, plasma or serum moves faster than blood cell components. The plasma or serum that has moved relatively fast reaches the blood cell stop filter 8 first and passes through the blood cell stop filter 8. Then, the plasma or serum passes through the hole 7a of the flow path closing member 7, flows down from the hollow flow path of the opening 2d of the container body 2, and flows into the second Housed in internal space A2.
[0073] 血漿若しくは血清よりも低速で移動した血球は、血球停止フィルタ 8に達しても、血 球停止フィルタ 8を通過しない。従って、第 2の内部空間 A2に収容された血漿若しく は血清に血球は混入しな!、。  [0073] Blood cells that have moved at a lower speed than plasma or serum do not pass through the blood cell stop filter 8 even if they reach the blood cell stop filter 8. Therefore, blood cells will not be mixed into the plasma or serum contained in the second internal space A2.
[0074] また、流路閉塞部材 7は、血漿若しくは血清に接触されることにより次第に膨潤し、 収容されるべき血漿若しくは血清が通過した後に流路を閉塞する。より具体的には、 血液分離フィルタ 6にお 、て相対的に速く移動した血漿または血清力 流路閉塞部 材 7が配置されている流路部分を通過した後、流路閉塞部材 7が膨潤する。すなわち 、流路閉塞部材 7の孔 7aが塞がり、流路閉塞部材 7が流路を閉塞させる。  [0074] In addition, the flow path closing member 7 gradually swells when it comes into contact with plasma or serum, and closes the flow path after the plasma or serum to be stored has passed. More specifically, the blood flow blocking member 7 swells after passing through the flow channel portion where the plasma or serum force flow channel blocking member 7 that has moved relatively fast in the blood separation filter 6 is disposed. To do. That is, the hole 7a of the flow path closing member 7 is closed, and the flow path closing member 7 closes the flow path.
[0075] 図 5に示すように、第 2の内部空間 A2に収容された血漿若しくは血清を取出す際 には、第 1の開口 2aが下方側、第 2の開口 2bが上方側となるように検体採取容器 1を 好ましくは上下反転させる。本発明では、流路が流路閉塞部材 7により閉塞されてい るため、検体採取容器 1を上下反転させることができ、第 2の内部空間 A2に収容され ている血漿若しくは血清力 血液分離フィルタ 6に至ることがない。すなわち、分離さ れた血漿若しくは血清が血球または赤血球内成分と接触し、血漿若しくは血清が汚 染されることが防がれている。  [0075] As shown in FIG. 5, when the plasma or serum stored in the second internal space A2 is taken out, the first opening 2a is on the lower side and the second opening 2b is on the upper side. The sample collection container 1 is preferably turned upside down. In the present invention, since the flow path is closed by the flow path closing member 7, the sample collection container 1 can be turned upside down, and the plasma or serum strength blood separation filter 6 contained in the second internal space A2 It does not lead to. That is, the separated plasma or serum is prevented from coming into contact with blood cells or erythrocyte components and contaminating the plasma or serum.
[0076] 図 5に示すように、分離された血漿若しくは血清を取出す際には、第 2の開口 2bに 圧入されている第 2の栓体 4を抜去する。し力る後、第 2の開口 2bから、ピペット等を 用いて血漿若しくは血清を容器に吸い取って、臨床検査に用いることができる。或い は、検査機器のノズルから、直接血漿若しくは血清を取出すこともできる。  [0076] As shown in FIG. 5, when the separated plasma or serum is taken out, the second plug 4 that is press-fitted into the second opening 2b is removed. After pressing, plasma or serum can be sucked into the container from the second opening 2b using a pipette or the like and used for clinical examination. Alternatively, plasma or serum can be taken directly from the nozzle of the test equipment.
[0077] 本発明では、容器本体 2の内周面にテーパー 2eが付けられており、血漿若しくは 血清の液面が第 2の開口 2bに近づけられているため、血漿若しくは血清をより一層 容易に取出すことが可能である。  [0077] In the present invention, the taper 2e is attached to the inner peripheral surface of the container body 2, and the plasma or serum liquid level is brought closer to the second opening 2b. It is possible to take it out.
[0078] 本発明の他の実施形態に係る検体採取容器を、図 6に正面図、図 7に正面断面図 で示す。  [0078] A sample collection container according to another embodiment of the present invention is shown in a front view in FIG. 6 and a front sectional view in FIG.
[0079] 図 6,図 7に示す検体採取容器 21は、第 1の開口の形状、および該第 1の開口に設 けられた第 1の栓体の形状が異なることを除いては、上述した検体採取容器 1と同様 に構成されている。以下の検体採取容器 21の説明では、検体採取容器 1と同様に 構成されているところは、同一の符号を付してその説明を省略する。 [0079] The sample collection container 21 shown in Figs. 6 and 7 is the same as that described above except that the shape of the first opening and the shape of the first stopper provided in the first opening are different. It is configured in the same way as the sample collection container 1. In the following description of the specimen collection container 21, the same as the specimen collection container 1 Where they are configured, the same reference numerals are given and description thereof is omitted.
[0080] 検体採取容器 21は、一端側に第 1の開口 22aを有し、他端側に第 2の開口 22bを 有する円筒状の容器本体 22を有する。本実施形態では、第 1の開口 22aと第 2の開 口 22bとが同じ開口径を有する。流路閉塞部材 7と第 2の内部空間 A2との間におい て、容器本体 22の内周面に、環状突部 22cが設けられている。この環状突部 22cに より、該環状突部 22cに囲まれた開口部 22dが形成されており、中空流路を構成して いる。容器本体 22の内周面の環状突部 22cには、流路閉塞部材 7側に向ってテー パー 22eが付けられて!/、る。  [0080] The sample collection container 21 has a cylindrical container body 22 having a first opening 22a on one end side and a second opening 22b on the other end side. In the present embodiment, the first opening 22a and the second opening 22b have the same opening diameter. An annular protrusion 22c is provided on the inner peripheral surface of the container body 22 between the flow path closing member 7 and the second internal space A2. The annular protrusion 22c forms an opening 22d surrounded by the annular protrusion 22c, and constitutes a hollow flow path. A taper 22e is attached to the annular protrusion 22c on the inner peripheral surface of the container body 22 toward the flow path closing member 7 side.
[0081] 第 1の開口 22aには、内部を気密封止するように第 1の栓体 23が嵌合されている。  [0081] A first plug 23 is fitted into the first opening 22a so as to hermetically seal the inside.
第 1の栓体 23は、大径部 23aと、小径部 23bとを有する。大径部 23aは小径部 23bよ りも大きな径を有する。大径部 23aは容器本体の外径よりも大きな径を有する。採血 針若しくはシリンジによる刺通を容易とするために、第 1の栓体 23の外側表面の中央 には、半球状の凹部 23cが設けられている。小径部 23bが第 1の開口 22aに圧入さ れており、第 1の栓体 23により第 1の開口 22aが気密封止されている。  The first plug body 23 has a large diameter portion 23a and a small diameter portion 23b. The large diameter portion 23a has a larger diameter than the small diameter portion 23b. The large diameter portion 23a has a diameter larger than the outer diameter of the container body. In order to facilitate piercing with a blood collection needle or a syringe, a hemispherical recess 23c is provided at the center of the outer surface of the first stopper 23. The small diameter portion 23b is press-fitted into the first opening 22a, and the first opening 22a is hermetically sealed by the first plug body 23.
[0082] 他方、カバー 5により外表面が覆われている第 2の栓体 4を用いて、第 2の開口 22b が気密封止されており、検体採取容器 21内は減圧されて 、る。  On the other hand, the second opening 22b is hermetically sealed using the second stopper 4 whose outer surface is covered with the cover 5, and the inside of the sample collection container 21 is decompressed.
[0083] 第 1の栓体 23の外表面は、カバー 24により覆われている。本実施形態では、第 1の 栓体 23が採血針若しくはシリンジにより刺通されるように、第 1の栓体 23の上記凹部 23c部分にお!、て、カバー 24には孔 24aが設けられて!/、る。  [0083] The outer surface of the first plug 23 is covered with a cover 24. In the present embodiment, the cover 24 is provided with a hole 24a in the concave portion 23c of the first plug 23 so that the first plug 23 is pierced by a blood collection needle or syringe. /!
[0084] カバー 24は大径部 23aの外周側面からさらに上方に延ばされており、カバー 24の 上端 24bは第 1の開口 22aの外周側面に至っている。カバー 24の内周側面には、環 状突部 24cが形成されている。カバー 24の内径は大径部 23aの外径と等しいか若し くはわずかに小さくされている力 環状突部 24c部分における内径は、小径部 23bの 外径と等しいか若しくはわずかに小さくされている。すなわち、環状突部 24cの先端 面 24dが小径部 23bの外周側面と当接されており、環状突部 24cの側面 24eが、大 径部 23aと小径部 23bとの段差部分 23cに当接されている。他方、容易に把持し得る ように、さらに第 1の栓体 23ごとカバー 24を容易に抜去し得るように、カバー 24の外 周側面には複数の段差 24fが形成されている。 [0085] 本実施形態のように、第 1の開口 22aが上記形状を有し、カバー 24により外表面が 覆われている第 1の栓体 23が、第 1の開口 22aに嵌合されている場合には、容器本 体 22およびカバー 24を手指で押さえつつ、第 1の栓体 23に採血針を刺入 '抜去す ることが容易となる。また、第 1の栓体 23ごとカバー 24を抜去することが容易であり、 例えば第 1の内部空間 A1に血液が過剰に導入された場合など、第 1の開口 22aから 過剰の血液を取出すことができる。さらに、血液を分離した後には、第 1の開口 22aを 下方側、第 2の開口 22bを上方側となるように検体採取容器 21を正立させることが容 易である。 [0084] The cover 24 extends further upward from the outer peripheral side surface of the large-diameter portion 23a, and the upper end 24b of the cover 24 reaches the outer peripheral side surface of the first opening 22a. On the inner peripheral side surface of the cover 24, an annular protrusion 24c is formed. The inner diameter of the cover 24 is equal to or slightly smaller than the outer diameter of the large diameter portion 23a.The inner diameter of the annular protrusion 24c is equal to or slightly smaller than the outer diameter of the small diameter portion 23b. Yes. That is, the front end surface 24d of the annular protrusion 24c is in contact with the outer peripheral side surface of the small diameter portion 23b, and the side surface 24e of the annular protrusion 24c is in contact with the step portion 23c between the large diameter portion 23a and the small diameter portion 23b. ing. On the other hand, a plurality of steps 24f are formed on the outer peripheral side surface of the cover 24 so that the cover 24 can be easily removed together with the first plug 23 so that it can be easily gripped. [0085] As in the present embodiment, the first opening 22a having the above-described shape and the outer surface of which is covered by the cover 24 is fitted into the first opening 22a. In this case, it is easy to insert and remove the blood collection needle from the first stopper 23 while holding the container body 22 and the cover 24 with fingers. In addition, it is easy to remove the cover 24 together with the first plug body 23. For example, when excessive blood is introduced into the first internal space A1, excessive blood can be removed from the first opening 22a. Can do. Furthermore, after separating the blood, it is easy to erect the sample collection container 21 so that the first opening 22a is on the lower side and the second opening 22b is on the upper side.
[0086] 本発明の別の実施形態に係る検体採取容器を、図 8に正面図、図 9に正面断面図 で示す。  [0086] A sample collection container according to another embodiment of the present invention is shown in a front view in FIG. 8 and a front sectional view in FIG.
[0087] 図 8,図 9に示す検体採取容器 31は、第 2の開口に嵌合されている第 2の栓体の形 状が異なることを除いては、上述した検体採取容器 1と同様に構成されている。  [0087] The sample collection container 31 shown in FIGS. 8 and 9 is the same as the sample collection container 1 described above except that the shape of the second stopper fitted in the second opening is different. It is configured.
[0088] 第 2の開口 2bには、内部を気密封止するように第 2の栓体 32が嵌合されている。第 2の栓体 32は、円錐台形状を有する大径部 32aと、小径部 32bとを有する。大径部 3 2aは小径部 32bよりも大きな径を有する。大径部 32aは容器本体の外径よりも大きな 径を有する。採血針若しくはシリンジによる刺通を容易とするために、第 2の栓体 32 の外側表面の中央には凹部 32cが設けられており、第 2の栓体 32の内側表面の中 央には凹部 32dが設けられている。小径部 32bが第 2の開口 2bに圧入されており、 第 2の栓体 32により第 2の開口 2bが気密封止されている。  [0088] A second plug 32 is fitted in the second opening 2b so as to hermetically seal the inside. The second plug 32 has a large diameter portion 32a having a truncated cone shape and a small diameter portion 32b. The large diameter portion 32a has a larger diameter than the small diameter portion 32b. The large diameter portion 32a has a diameter larger than the outer diameter of the container body. In order to facilitate piercing with a blood collection needle or syringe, a recess 32c is provided in the center of the outer surface of the second plug 32, and a recess is formed in the center of the inner surface of the second plug 32. 32d is provided. The small diameter portion 32b is press-fitted into the second opening 2b, and the second opening 2b is hermetically sealed by the second plug 32.
[0089] 本実施形態のように、第 2の栓体 32が、採血針やシリンジにより刺通されるように構 成されている場合には、血液を分離した後に、第 2の内部空間 A2に収容されている 血漿若しくは血清を、採血針やシリンジを用いて容易に採取することができる。よって 、血漿若しくは血清を取出す際に、第 2の栓体 32を抜去しなくてもよいため、第 2の 開口 2bから血漿若しくは血清が溢れ出るのを防ぐことができる。  [0089] When the second stopper 32 is configured to be pierced by a blood collection needle or syringe as in the present embodiment, the second internal space A2 is separated after blood is separated. Plasma or serum contained in the can be easily collected using a blood collection needle or syringe. Therefore, since it is not necessary to remove the second plug 32 when taking out the plasma or serum, it is possible to prevent the plasma or serum from overflowing from the second opening 2b.
[0090] 本発明のさらに別の実施形態に係る検体採取容器を、図 10及び図 11にそれぞれ 正面断面図で示す。  [0090] A sample collection container according to still another embodiment of the present invention is shown in front sectional views in FIGS.
[0091] 図 10に示す検体採取容器 41,図 11に示す検体採取容器 51は、流路閉塞部材の 配置部分若しくは材質が異なることを除いては、上述した検体採取容器 1と同様に構 成されている。 [0091] The sample collection container 41 shown in FIG. 10 and the sample collection container 51 shown in FIG. 11 are configured in the same manner as the sample collection container 1 described above except that the arrangement part or material of the flow path closing member is different. It is made.
[0092] 図 10に示すように、検体採取容器 41では、流路閉塞部材 42は血漿若しくは血清 に接触されることにより膨潤する樹脂と熱可塑性榭脂との混合物により構成されてい る。初期状態、すなわち膨潤前に血漿若しくは血清が流れる流路を確保するように、 流路閉塞部材 42の中央に孔 42aが形成されている。本実施形態のように、血漿若し くは血清に接触されることにより膨潤し、流路を閉塞する作用を果たし得る限り、流路 閉塞部材は、血漿若しくは血清に接触されることにより膨潤する樹脂と熱可塑性榭脂 との混合物により構成されて 、てもよ 、。  As shown in FIG. 10, in the sample collection container 41, the flow path closing member 42 is composed of a mixture of a resin that swells when it comes into contact with plasma or serum and a thermoplastic resin. A hole 42a is formed at the center of the channel closing member 42 so as to secure a channel through which plasma or serum flows in the initial state, that is, before swelling. As in this embodiment, as long as it can swell when contacted with plasma or serum and act to close the channel, the channel closing member swells when contacted with plasma or serum It is composed of a mixture of resin and thermoplastic resin.
[0093] 図 11に示すように、検体採取容器 51は、一端側に第 1の開口 52aを有し、他端側 に第 2の開口 52bを有する円筒状の容器本体 52を有する。容器本体 52の内周面に 、環状突部 52cが設けられている。この環状突部 52cの先端部分が、血漿若しくは血 清に接触されることにより膨潤する樹脂の成形体力もなり流路閉塞部材 52dを構成し ている。すなわち、該流路閉塞部材 52dに囲まれた開口部 52eが、中空流路を構成 している。なお、容器本体 52の内周面の環状突部 52cには、流路閉塞部材 52d側に 向ってテーパー 52fが付けられて!/、る。  As shown in FIG. 11, the sample collection container 51 has a cylindrical container body 52 having a first opening 52a on one end side and a second opening 52b on the other end side. An annular protrusion 52 c is provided on the inner peripheral surface of the container body 52. The distal end portion of the annular protrusion 52c also has a molded body force of a resin that swells when it comes into contact with plasma or blood, and constitutes a flow path closing member 52d. That is, the opening 52e surrounded by the flow path closing member 52d constitutes a hollow flow path. The annular protrusion 52c on the inner peripheral surface of the container main body 52 is provided with a taper 52f toward the flow path closing member 52d side.
[0094] 本実施形態のように、血漿若しくは血清に接触されることにより膨潤し、流路を閉塞 する作用を果たし得る限り、容器本体の一部が、血漿若しくは血清に接触されること により膨潤する樹脂の成形体力もなる流路閉塞部材により構成されていてもよい。 次に、血液拡散材が備えられた実施形態を説明する。図 12 (a) , (b)は、血液拡散 材が備えられた本発明のさらに他の実施形態に係る検体採取容器の正面図及び正 面断面図である。  [0094] As in the present embodiment, as long as it swells by being in contact with plasma or serum and can serve to block the flow path, a part of the container body swells by being in contact with plasma or serum. It may be configured by a flow path closing member that also has a molded body strength of the resin to be processed. Next, an embodiment provided with a blood diffusion material will be described. FIGS. 12 (a) and 12 (b) are a front view and a front sectional view of a sample collection container according to still another embodiment of the present invention provided with a blood diffusion material.
本実施形態の検体採取容器 61では、容器本体 62の一端に第 1の開口 62aが、他 端に第 2の開口 62bが設けられている。そして、容器本体 62は、第 1の開口 62a側の 第 1の内部空間 A1と、第 2の開口 62b側の第 2の内部空間 A2とを有する。また、第 1 の開口 62aは、第 1の栓体 63で気密的に閉栓されており、第 2の開口 62bは、第 2の 栓体 64により気密的に閉栓されている。第 2の栓体 64の外側には、カバー 5と同様 に構成されたカバー 65が設けられている。上記第 1の栓体 63は、外側に開いた凹部 63cが設けられている。この凹部 63cを設けることにより、第 1の栓体 63の中央部が薄 肉化されて、後述する採血針による刺通抵抗が低められている。なお、上記第 1の栓 体 63は、相対的に小さな径の小径部 63bと、先端に設けられた相対的に径の大きな 大径部 63aとを有する。 In the sample collection container 61 of the present embodiment, a first opening 62a is provided at one end of the container body 62, and a second opening 62b is provided at the other end. The container main body 62 has a first internal space A1 on the first opening 62a side and a second internal space A2 on the second opening 62b side. The first opening 62 a is hermetically closed by the first plug 63, and the second opening 62 b is hermetically closed by the second plug 64. A cover 65 configured in the same manner as the cover 5 is provided outside the second plug 64. The first plug 63 is provided with a recess 63c that opens outward. By providing the recess 63c, the central portion of the first plug 63 is thin. It is fleshed and the puncture resistance by the blood collection needle mentioned later is lowered. The first plug 63 has a relatively small diameter portion 63b and a relatively large diameter portion 63a provided at the tip.
他方、第 2の栓体 64は、前述した第 2の栓体 4と同様に構成されているので、相当 の部分については相当の参照番号を付することにより、その説明を省略する。カバー 65についても、カバー 5と同様に構成されているので、相当の部分については相当 の参照番号を付することにより、その説明を省略する。  On the other hand, since the second plug body 64 is configured in the same manner as the second plug body 4 described above, the corresponding parts will be denoted by the corresponding reference numerals and the description thereof will be omitted. The cover 65 is also configured in the same manner as the cover 5, so that the corresponding parts are denoted by the corresponding reference numerals and the description thereof is omitted.
また、容器本体 62内においては、第 1の開口 62a側に、すなわち第 1の内部空間 A 1内に血液分離フィルタ 6が配置されている。また、血液分離フィルタ 6の後段には、 血球停止フィルタ 8が配置されて!、る。血液分離フィルタ 6及び血球停止フィルタ 8は 、図 1に示した実施形態の血液分離フィルタ 6及び血球停止フィルタ 8と同様に構成 されている。  In the container main body 62, the blood separation filter 6 is disposed on the first opening 62a side, that is, in the first inner space A1. In addition, a blood cell stop filter 8 is disposed after the blood separation filter 6! The blood separation filter 6 and the blood cell stop filter 8 are configured in the same manner as the blood separation filter 6 and the blood cell stop filter 8 of the embodiment shown in FIG.
本実施形態の特徴は、上記血液分離フィルタ 6の前段に、すなわち第 1の開口 62a 側に、血液拡散材 67が配置されていることである。血液拡散材 7は、第 1の開口 62a 力も供給された血液が血液分離フィルタ 6よりも先に接触されるように、第 1の栓体 63 と血液分離フィルタ 6との間に配置されている。必ずしも限定されないが、本実施形 態では、血液拡散材 67は、血液分離フィルタ 6に接触するように配置されている。 上記血液拡散材 67は、様々な材料で構成することができ、特に限定されないが、 例えば、ポリエチレン、ポリプロピレン、ポリエチレンテレフタレート、  A feature of the present embodiment is that a blood diffusion material 67 is disposed in the front stage of the blood separation filter 6, that is, on the first opening 62a side. The blood diffusion material 7 is disposed between the first plug 63 and the blood separation filter 6 so that the blood supplied with the force of the first opening 62a is brought into contact with the blood separation filter 6 earlier. . Although not necessarily limited, in this embodiment, the blood diffusion material 67 is disposed so as to contact the blood separation filter 6. The blood diffusion material 67 can be composed of various materials and is not particularly limited. For example, polyethylene, polypropylene, polyethylene terephthalate,
ポリブチレンテレフタレート、ポリスチレン、ポリ酢酸ビニル、ウレタン榭脂、アクリル榭 脂、などの構成榭脂、あるいはレーヨンなどの半合成繊維またはガラス繊維などによ り形成することができる。  It can be formed from a constituent resin such as polybutylene terephthalate, polystyrene, polyvinyl acetate, urethane resin, acrylic resin, semi-synthetic fiber such as rayon, or glass fiber.
[0095] 血液拡散材 67は、血液を様々な方向に拡散するために複数の孔を有することが好 まし ヽ。血液拡散材の孑し径 ίま、 15〜2000 111の範囲カ好ましく、 20〜: LOOO /z mの 範囲がより好ましい。孔径が 15〜2000 /ζ πιの範囲であると、血液拡散材 6内で血液 が多方向により一層効果的に拡散する。  [0095] The blood diffusion material 67 preferably has a plurality of holes in order to diffuse blood in various directions. The diameter of the blood diffusing material is preferably in the range of 15 to 2000 111, more preferably in the range of 20 to LOOO / zm. When the pore diameter is in the range of 15 to 2000 / ζ πι, blood diffuses more effectively in the blood diffusion material 6 in multiple directions.
[0096] 複数の孔により形成される血液拡散材の空隙率は、 50〜97%の範囲が好ましぐ 60〜95%の範囲がより好ましい。空隙率が 50〜97%の範囲であると、血液拡散材 67内で血液が多方向により一層効果的に拡散する。 [0096] The porosity of the blood diffusion material formed by a plurality of pores is preferably in the range of 50 to 97%, more preferably in the range of 60 to 95%. When the porosity is in the range of 50 to 97%, the blood diffusion material Within 67, blood diffuses more effectively in multiple directions.
また、上記血球停止フィルタ 8の後段においては、流路閉塞部材 7が配置されてい る。流路閉塞部材 7は、図 1に示した実施形態の流路閉塞部材 7と同様に孔 7aを有 し、同様に構成されている。上記第 1の内部空間 A1に、上記血液拡散材 67、血液分 離フィルタ 6、血球停止フィルタ 8が配置されており、上記流路閉塞部材 7が、第 1の 内部空間 A1と第 2の内部空間 A2との間に配置されている。  Further, a flow path blocking member 7 is disposed in the subsequent stage of the blood cell stop filter 8. The channel closing member 7 has the same hole 7a as the channel closing member 7 of the embodiment shown in FIG. The blood diffusing material 67, the blood separation filter 6, and the blood cell stop filter 8 are disposed in the first internal space A1, and the flow path blocking member 7 is connected to the first internal space A1 and the second internal space A1. It is placed between space A2.
[0097] 図 13〜図 16を用いて、上述した本実施形態に係る検体採取容器 1の使用方法を 以下説明する。図 13〜図 16には、血液を血球と血漿または血清とに分離し、さらに 分離された血漿または血清を取出すまでの過程が段階的に示されている。  [0097] A method of using the specimen collection container 1 according to this embodiment described above will be described below with reference to FIGS. FIG. 13 to FIG. 16 show a step-by-step process until blood is separated into blood cells and plasma or serum, and the separated plasma or serum is taken out.
[0098] 図 13に、血液が採取されたシリンジを検体採取容器 61内に刺通する前の状態、図 14に、血液が採取されたシリンジ力 検体採取容器 61内に血液を流入させて!/、る途 中段階の状態をそれぞれ正面断面図で示す。図 15に、分離された血漿または血清 が内部空間に収容された後の状態、図 16に、検体採取容器 1から分離された血漿ま たは血清を取出すときの状態をそれぞれ正面断面図で示す。図 13〜15には、検体 採取容器 61が図 12に示す状態と上下が逆にされた状態で示されている。  [0098] Fig. 13 shows a state before a syringe from which blood has been collected is inserted into the sample collection container 61, and Fig. 14 shows a syringe force from which blood has been collected. Inject blood into the sample collection container 61! / The state of the middle stage is shown in front sectional view. Fig. 15 shows the state after the separated plasma or serum is stored in the internal space, and Fig. 16 shows the state when the separated plasma or serum is taken out from the specimen collection container 1 in a front sectional view. . 13 to 15 show the specimen collection container 61 in a state where the state shown in FIG. 12 is turned upside down.
[0099] 図 13に示すように、血液を分離する際には、第 1の開口 62aが上方側、第 2の開口 62bが下方側となるように検体採取容器 61を配置する。  As shown in FIG. 13, when separating blood, the specimen collection container 61 is arranged so that the first opening 62a is on the upper side and the second opening 62b is on the lower side.
[0100] 先ず、例えばシリンジ 71に血液を採取する。シリンジ 71の中空針 72の針先 72a側 には、上述した第 1の栓体 63の凹部 63cと気密的に嵌合し得るハブ 73が設けられて いる。ハブ 73により、中空針 72の第 1の栓体 63への挿入距離が規制されている。す なわち、シリンジ 71は、第 1の栓体 63に挿入されたときに、針先 72aが血液分離フィ ルタ 6に至らないように、かつ針先 72aが血液拡散材 7内まで挿入され得るように構成 されている。  First, for example, blood is collected in the syringe 71. On the side of the needle tip 72a of the hollow needle 72 of the syringe 71, a hub 73 that can be airtightly fitted to the concave portion 63c of the first plug 63 described above is provided. The hub 73 restricts the insertion distance of the hollow needle 72 into the first plug 63. That is, when the syringe 71 is inserted into the first stopper 63, the needle tip 72a does not reach the blood separation filter 6 and the needle tip 72a can be inserted into the blood diffusion material 7. It is configured as follows.
[0101] 次に、図 14に示すように、ハブ 73を凹部 63cに嵌合させつつ、中空針 72を第 1の 栓体 63に刺通させ、針先 72aを血液拡散材 67内に至らせる。し力る後、血液拡散材 7内に血液が流入される。第 1の開口 62aから流入された血液は、血液分離フィルタ 6 よりも先に血液拡散材 67に接触される。  Next, as shown in FIG. 14, while the hub 73 is fitted in the recess 63c, the hollow needle 72 is pierced through the first plug 63, and the needle tip 72a reaches the blood diffusion material 67. Make it. After this, blood flows into the blood diffusion material 7. The blood flowing in from the first opening 62a comes into contact with the blood diffusion material 67 prior to the blood separation filter 6.
[0102] 本実施形態では、検体採取容器 61内が減圧されているため、検体採取容器 61内 とシリンジ 71内との圧力差によって、検体採取容器 1内に血液が速やかに真空吸引 される。すなわち、シリンジ 71のピストンが血液の流入に伴い移動し、シリンジ 71内の 大気圧が維持されて、検体採取容器 1内の減圧度に従って速やかに血液が検体採 取容器 6内に流入する。 [0102] In this embodiment, since the inside of the sample collection container 61 is depressurized, The blood is quickly sucked into the sample collection container 1 by the pressure difference between the syringe 71 and the syringe 71. That is, the piston of the syringe 71 moves as blood flows in, the atmospheric pressure in the syringe 71 is maintained, and blood quickly flows into the sample collection container 6 according to the degree of pressure reduction in the sample collection container 1.
[0103] 図 14に示すように、血液は血液拡散材 67内に流入されることが好ましい。血液が 血液拡散材 67内に直接流入されると、血液の流入時に血球が血液拡散材 67に高 速で衝突し、血球が破壊されることを防止できる。血液拡散材 67内に流入された血 液は、血液拡散材 67内で多方向に拡散する。よって、血液拡散材 67内で多方向に 拡散した血液は、血液分離フィルタ 6の第 1の開口 62a側の表面 6a全体力 流入さ れる。 As shown in FIG. 14, the blood is preferably flowed into the blood diffusion material 67. When blood flows directly into the blood diffusing material 67, it is possible to prevent blood cells from colliding with the blood diffusing material 67 at a high speed when the blood flows in and destroying the blood cells. The blood fluid that has flowed into the blood diffusion material 67 diffuses in multiple directions within the blood diffusion material 67. Accordingly, the blood diffused in multiple directions in the blood diffusion material 67 flows into the entire surface 6a of the blood separation filter 6 on the first opening 62a side.
[0104] 以下図 15及び図 16に示すように、図 1に示した実施形態の場合と同様にして、血 液から血漿もしくは血清が分離され、第 2の内部空間 A2において、分離された血漿 もしくは血清を取り出すことができる。  As shown in FIGS. 15 and 16, hereinafter, plasma or serum is separated from the blood in the same manner as in the embodiment shown in FIG. 1, and the separated plasma is separated in the second internal space A2. Alternatively, serum can be removed.
[0105] 本発明のさらに他の実施形態に係る検体採取容器を、図 17 (a)に正面図、図 17 ( b)に正面断面図でそれぞれ示す。  A sample collection container according to still another embodiment of the present invention is shown in a front view in FIG. 17 (a) and in a front sectional view in FIG. 17 (b).
[0106] 図 17 (a) , (b)に示す検体採取容器 81は、第 1の開口の形状、および該第 1の開 口に設けられた第 1の栓体の形状が異なることを除いては、上述した検体採取容器 6 1と同様に構成されている。以下の検体採取容器 81の説明では、検体採取容器 61 と同様に構成されているところは、同一の符号を付してその説明を省略する。  [0106] The sample collection container 81 shown in Figs. 17 (a) and 17 (b) is different except that the shape of the first opening and the shape of the first stopper provided in the first opening are different. The configuration is the same as that of the sample collection container 61 described above. In the following description of the sample collection container 81, components that are configured in the same manner as the sample collection container 61 are denoted by the same reference numerals and description thereof is omitted.
[0107] 検体採取容器 81は、一端側に第 1の開口 82aを有し、他端側に第 2の開口 82bを 有する円筒状の容器本体 82を有する。本実施形態では、第 1の開口 82aと第 2の開 口 82bとが同じ開口径を有する。流路閉塞部材 8と第 2の内部空間 A2との間におい て、容器本体 82の内周面に、環状突部 82cが設けられている。この環状突部 82cに より、該環状突部 82cに囲まれた開口部 82dが形成されており、中空流路を構成して いる。容器本体 82の内周面の環状突部 82cには、第 1の開口 82a側に向ってテーパ 一 82eが付けられている。  [0107] The sample collection container 81 has a cylindrical container body 82 having a first opening 82a on one end side and a second opening 82b on the other end side. In the present embodiment, the first opening 82a and the second opening 82b have the same opening diameter. An annular protrusion 82c is provided on the inner peripheral surface of the container body 82 between the flow path closing member 8 and the second internal space A2. The annular protrusion 82c forms an opening 82d surrounded by the annular protrusion 82c, and constitutes a hollow flow path. A taper 82e is attached to the annular protrusion 82c on the inner peripheral surface of the container body 82 toward the first opening 82a.
[0108] 第 1の開口 82aには、内部を気密封止するように第 1の栓体 83が取付けられている 。第 1の栓体 83は、大径部 83aと、小径部 83bとを有する。大径部 83aは小径部 83b よりも大きな径を有する。大径部 83aは容器本体の外径よりも大きな径を有する。採 血針若しくはシリンジによる刺通を容易とするために、第 1の栓体 83の外側表面の中 央には、半球状の凹部 83cが設けられている。小径部 83bが第 1の開口 82aに圧入 されており、第 1の栓体 83により第 1の開口 82aが気密封止されている。 [0108] A first plug 83 is attached to the first opening 82a so as to hermetically seal the inside. The first plug 83 has a large diameter part 83a and a small diameter part 83b. Large diameter part 83a is small diameter part 83b Have a larger diameter. The large diameter portion 83a has a diameter larger than the outer diameter of the container body. In order to facilitate piercing with a blood collection needle or a syringe, a hemispherical recess 83c is provided in the center of the outer surface of the first stopper 83. The small diameter portion 83b is press-fitted into the first opening 82a, and the first opening 82a is hermetically sealed by the first plug 83.
[0109] 他方、カバー 65により外表面が覆われている第 2の栓体 64を用いて、第 2の開口 8 2bが気密封止されており、検体採取容器 81内は減圧されて 、る。  On the other hand, the second opening 82 b is hermetically sealed using the second plug 64 whose outer surface is covered by the cover 65, and the inside of the sample collection container 81 is decompressed. .
[0110] 第 1の栓体 83の外表面は、カバー 84により覆われている。本実施形態では、第 1の 栓体 83が採血針若しくはシリンジにより刺通されるように、第 1の栓体 83の上記凹部 83c部分にお!、て、カバー 84には孔 84aが設けられて!/、る。  The outer surface of the first plug 83 is covered with a cover 84. In this embodiment, the cover 84 is provided with a hole 84a in the concave portion 83c of the first plug 83 so that the first plug 83 is pierced by a blood collection needle or syringe. /!
[0111] カバー 84は大径部 83aの外周側面からさらに上方に延ばされており、カバー 84の 上端 84bは第 1の開口 82aの外周側面に至っている。カバー 84の内周側面には、環 状突部 84cが形成されている。カバー 84の内径は大径部 83aの外径と等しいか若し くはわずかに小さくされている力 環状突部 84c部分における内径は、小径部 83bの 外径と等しいか若しくはわずかに小さくされている。すなわち、環状突部 84cの先端 面 84dが小径部 83bの外周側面と当接されており、環状突部 84cの側面 84eが、大 径部 83aと小径部 83bとの段差部分 83cに当接されている。他方、容易に把持し得る ように、さらに第 1の栓体 83ごとカバー 84を容易に抜去し得るように、カバー 84の外 周側面には複数の段差 84fが形成されている。  [0111] The cover 84 extends further upward from the outer peripheral side surface of the large-diameter portion 83a, and the upper end 84b of the cover 84 reaches the outer peripheral side surface of the first opening 82a. On the inner peripheral side surface of the cover 84, an annular protrusion 84c is formed. The inner diameter of the cover 84 is equal to or slightly smaller than the outer diameter of the large diameter portion 83a.The inner diameter of the annular projection 84c is equal to or slightly smaller than the outer diameter of the small diameter portion 83b. Yes. That is, the tip end surface 84d of the annular protrusion 84c is in contact with the outer peripheral side surface of the small diameter portion 83b, and the side surface 84e of the annular protrusion 84c is in contact with the step portion 83c between the large diameter portion 83a and the small diameter portion 83b. ing. On the other hand, a plurality of steps 84f are formed on the outer peripheral side surface of the cover 84 so that the cover 84 can be easily removed together with the first plug 83 so that it can be easily gripped.
[0112] 本実施形態のように、第 1の開口 82aが上記形状を有し、カバー 24により外表面が 覆われている第 1の栓体 83が、第 1の開口 82aに取付けられている場合には、容器 本体 82およびカバー 84を手指で押さえつつ、第 1の栓体 83に採血針を刺入、抜去 することが容易となる。また、第 1の栓体 83ごとカバー 84を抜去することが容易である 。さらに、血液を分離した後には、第 1の開口 82aを下方側、第 2の開口 82bを上方 側となるように検体採取容器 81を正立させることが容易である。  [0112] As in the present embodiment, the first opening 82a has the above-described shape, and the first plug 83 having the outer surface covered by the cover 24 is attached to the first opening 82a. In this case, the blood collection needle can be easily inserted and removed from the first plug 83 while holding the container body 82 and the cover 84 with fingers. Further, it is easy to remove the cover 84 together with the first plug 83. Furthermore, after separating the blood, it is easy to erect the sample collection container 81 so that the first opening 82a is on the lower side and the second opening 82b is on the upper side.
[0113] 本発明のさらに別の実施形態に係る検体採取容器を、図 18 (a)に正面図、図 18 ( b)に正面断面図で示す。  [0113] A specimen collection container according to still another embodiment of the present invention is shown in a front view in FIG. 18 (a) and in a front sectional view in FIG. 18 (b).
[0114] 図 18 (a) , (b)に示す検体採取容器 91は、第 2の開口に取付けられている第 2の栓 体の形状が異なることを除 ヽては、上述した検体採取容器 61と同様に構成されて!ヽ る。 [0114] The specimen collection container 91 shown in Figs. 18 (a) and 18 (b) is the same as the specimen collection container described above except that the shape of the second stopper attached to the second opening is different. Constructed like 61! ヽ The
第 2の開口 62bには、内部を気密封止するように第 2の栓体 92が取付けられている 。第 2の栓体 92は、円錐台形状を有する大径部 92aと、小径部 92bとを有する。大径 部 92aは小径部 92bよりも大きな径を有する。大径部 92aは容器本体の外径よりも大 きな径を有する。採血針若しくはシリンジによる刺通を容易とするために、第 2の栓体 92の外側表面の中央には凹部 92cが設けられており、第 2の栓体 92の内側表面の 中央には凹部 92dが設けられている。小径部 92bが第 2の開口 62bに圧入されてお り、第 2の栓体 92により第 2の開口 62bが気密封止されている。  A second plug 92 is attached to the second opening 62b so as to hermetically seal the inside. The second plug 92 has a large-diameter portion 92a having a truncated cone shape and a small-diameter portion 92b. The large diameter portion 92a has a larger diameter than the small diameter portion 92b. The large diameter portion 92a has a diameter larger than the outer diameter of the container body. In order to facilitate piercing with a blood collection needle or syringe, a recess 92c is provided in the center of the outer surface of the second stopper 92, and a recess 92d is provided in the center of the inner surface of the second stopper 92. Is provided. The small diameter portion 92b is press-fitted into the second opening 62b, and the second opening 62b is hermetically sealed by the second plug 92.

Claims

請求の範囲 The scope of the claims
[1] 血液から血漿若しくは血清を分離し、該血漿若しくは血清中の成分を検査するのに 用いられる検体採取容器であって、  [1] A specimen collection container used for separating plasma or serum from blood and examining components in the plasma or serum,
一端側に第 1の開口を有し、他端側に第 2の開口を有する筒状の容器本体と、前 記第 1の開口に嵌合されている第 1の栓体と、前記第 2の開口に嵌合されている第 2 の栓体とを備え、  A cylindrical container body having a first opening on one end side and a second opening on the other end side, a first stopper fitted in the first opening, and the second A second plug fitted in the opening of the
前記筒状の容器本体が、前記第 1の開口側に配置されておりかっ血液が採取され る第 1の内部空間と、前記第 2の開口側に配置されておりかっ血液から分離された血 漿若しくは血清が収容される第 2の内部空間とを有し、  The cylindrical container body is disposed on the first opening side and the blood is separated from the first internal space from which the blood is collected and the second opening side. A second interior space in which serum or serum is contained;
前記第 1の内部空間に配置されており、前記第 1の内部空間に採取された血液を 血球成分と血漿若しくは血清とに分離するための血液分離フィルタをさらに備えるこ とを特徴とする、検体採取容器。  A specimen further comprising a blood separation filter that is disposed in the first internal space and separates blood collected in the first internal space into a blood cell component and plasma or serum. Collection container.
[2] 前記第 1の開口側力 供給された血液が前記血液分離フィルタよりも先に接触され るように前記第 1の栓体と前記血液分離フィルタとの間に配置されており、かっ血液 を内部で様々な方向に拡散させつつ通過させて血液を前記血液分離フィルタに流 入させる血液拡散材をさらに備えることを特徴とする、請求項 1に記載の検体採取容 [2] The first opening side force is arranged between the first stopper and the blood separation filter so that the supplied blood is brought into contact with the blood separation filter before the blood is separated. The specimen collection container according to claim 1, further comprising a blood diffusion material that allows the blood to flow into the blood separation filter by allowing the blood to pass through while being diffused in various directions.
[3] 前記血液分離フィルタと前記第 2の内部空間との間に配置されており、前記血液分 離フィルタにより分離された血球成分の通過を防止する血球停止フィルタをさらに備 える、請求項 1または 2に記載の検体採取容器。 [3] The blood cell stop filter is further disposed between the blood separation filter and the second internal space, and further prevents a blood cell component separated by the blood separation filter from passing therethrough. Or Sample collection container according to 2.
[4] 前記血液分離フィルタと前記第 2の内部空間との間に配置されており、前記血液分 離フィルタにより分離された血漿若しくは血清に接触されることにより膨潤し、流路を 閉塞する流路閉塞部材をさらに備えることを特徴とする、請求項 1〜3のいずれかに 記載の検体採取容器。  [4] A flow that is disposed between the blood separation filter and the second internal space, swells by contact with plasma or serum separated by the blood separation filter, and closes the flow path. The specimen collection container according to any one of claims 1 to 3, further comprising a path blocking member.
[5] 前記流路閉塞部材が、前記血球停止フィルタと前記第 2の内部空間との間に配置 されている、請求項 4に記載の検体採取容器。  [5] The specimen collection container according to claim 4, wherein the flow path blocking member is disposed between the blood cell stop filter and the second internal space.
[6] 前記第 2の栓体の外表面が、前記第 2の栓体が採血針またはシリンジにより刺通さ れるのを防止するカバーにより覆われている、請求項 1〜5のいずれ力 1項に記載の 検体採取容器。 [6] The force according to any one of claims 1 to 5, wherein an outer surface of the second stopper is covered with a cover that prevents the second stopper from being pierced by a blood collection needle or a syringe. Described in Sample collection container.
[7] 前記筒状の容器本体の内周面に、前記第 1の開口側に向ってテーパーが付けられ ている、請求項 1〜6のいずれ力 1項に記載の検体採取容器。  7. The specimen collection container according to any one of claims 1 to 6, wherein an inner peripheral surface of the cylindrical container main body is tapered toward the first opening side.
[8] 前記第 1,第 2の栓体が、前記容器本体の第 1,第 2の開口に気密的に取り付けら れており、前記容器本体内が減圧されている、請求項 1〜7のいずれか 1項に記載の 検体採取容器。 [8] The first and second stoppers are hermetically attached to the first and second openings of the container body, and the pressure inside the container body is reduced. The sample collection container according to any one of the above.
PCT/JP2006/312706 2005-06-27 2006-06-26 Container for sampleing specimen WO2007000966A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2005-187124 2005-06-27
JP2005187124A JP3890068B2 (en) 2005-06-27 2005-06-27 Sample collection container
JP2005187123A JP3890067B2 (en) 2005-06-27 2005-06-27 Sample collection container
JP2005-187123 2005-06-27

Publications (1)

Publication Number Publication Date
WO2007000966A1 true WO2007000966A1 (en) 2007-01-04

Family

ID=37595217

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2006/312706 WO2007000966A1 (en) 2005-06-27 2006-06-26 Container for sampleing specimen

Country Status (1)

Country Link
WO (1) WO2007000966A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8309343B2 (en) 2008-12-01 2012-11-13 Baxter International Inc. Apparatus and method for processing biological material
WO2014025490A1 (en) * 2012-08-10 2014-02-13 Montagu Jean I Filtering blood
CN105148569A (en) * 2015-07-02 2015-12-16 周建明 Integrated autologous platelet rich gel preparation set
WO2020013981A1 (en) 2018-07-09 2020-01-16 Hanuman Pelican, Inc. Apparatus and methods for processing blood

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001321367A (en) * 2000-05-16 2001-11-20 Fuji Photo Film Co Ltd Plasma or serum taking tool
JP2004344874A (en) * 2002-11-19 2004-12-09 Sekisui Chem Co Ltd Separation membrane of plasma or serum and filter apparatus using separation membrane of plasma or serum
JP2005009888A (en) * 2003-06-16 2005-01-13 Sekisui Chem Co Ltd Vessel for blood test and blood testing method

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001321367A (en) * 2000-05-16 2001-11-20 Fuji Photo Film Co Ltd Plasma or serum taking tool
JP2004344874A (en) * 2002-11-19 2004-12-09 Sekisui Chem Co Ltd Separation membrane of plasma or serum and filter apparatus using separation membrane of plasma or serum
JP2005009888A (en) * 2003-06-16 2005-01-13 Sekisui Chem Co Ltd Vessel for blood test and blood testing method

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9423327B2 (en) 2008-12-01 2016-08-23 Baxalta GmbH Apparatus and method for processing biological material
US8309343B2 (en) 2008-12-01 2012-11-13 Baxter International Inc. Apparatus and method for processing biological material
US9097631B2 (en) 2008-12-01 2015-08-04 Baxter International Inc. Apparatus and method for processing biological material
US9176038B2 (en) 2008-12-01 2015-11-03 Baxalta Incorporated Apparatus and method for processing biological material
US9182328B2 (en) 2008-12-01 2015-11-10 Baxalta Incorporated Apparatus and method for processing biological material
US10531822B2 (en) 2012-08-10 2020-01-14 Jean I. Montagu Filtering in pre-evacuated containers
WO2014025490A1 (en) * 2012-08-10 2014-02-13 Montagu Jean I Filtering blood
US9427707B2 (en) 2012-08-10 2016-08-30 Jean I. Montagu Filtering blood
WO2017000851A1 (en) * 2015-07-02 2017-01-05 浙江康慈医疗科技有限公司 Integrated autologous platelet-rich gel preparation kit
CN105148569A (en) * 2015-07-02 2015-12-16 周建明 Integrated autologous platelet rich gel preparation set
CN105148569B (en) * 2015-07-02 2017-03-01 周建明 A kind of integration autologous platelet rich gel preparation suit
WO2020013981A1 (en) 2018-07-09 2020-01-16 Hanuman Pelican, Inc. Apparatus and methods for processing blood
EP3820541A4 (en) * 2018-07-09 2022-04-06 Hanuman Pelican, Inc. Apparatus and methods for processing blood
US11534534B2 (en) 2018-07-09 2022-12-27 Hanuman Pelican, Inc. Apparatus and methods for processing blood
US11534533B2 (en) 2018-07-09 2022-12-27 Hanuman Pelican, Inc. Apparatus and methods for processing blood

Similar Documents

Publication Publication Date Title
JP3890066B2 (en) Blood separation instrument and blood separation device
ES2650612T3 (en) Double layer membrane based tube for sample collection
AU2012203289B2 (en) Plasma separation
US20210315550A1 (en) Specimen collection and delivery apparatus
US20030206828A1 (en) Whole blood sampling device
JP4387166B2 (en) Filter device using plasma or serum separation membrane and plasma or serum separation method
JP2008253452A (en) Vacuum blood collection tube
JP2007304016A (en) Blood separation apparatus
WO2007000966A1 (en) Container for sampleing specimen
JP4113464B2 (en) Blood test container and blood test method
JP2007003478A (en) Blood separation material, blood separation device, and vacuum specimen collection container
JP2007010468A (en) Vacuum specimen collection container and blood separation device
JP2007006973A (en) Blood sampling and separating apparatus
JP3890068B2 (en) Sample collection container
JP2007003479A (en) Blood separation device
JP2008232876A (en) Hemocyte stop membrane, blood separation filter, blood separator, and specimen sampling container
JP4391761B2 (en) Blood test container
JP3890067B2 (en) Sample collection container
JP2008279195A (en) Blood separation filter device
JP3809457B2 (en) Blood separation filter device and vacuum sample collection tube
JP2007003481A (en) Blood separation device
JP2008245778A (en) Vacuum blood collecting tube
JP4021796B2 (en) Sample collection container
JP2007000537A (en) Vacuum specimen collecting instrument
JP2007330757A (en) Blood separation apparatus

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06767323

Country of ref document: EP

Kind code of ref document: A1